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ABSTRACT
ANAL YSIS OF THE MECHANISM OF Ras ACTIV A TION:
MAPPING OF IMPORTANT FUNCTIONAL DOMAINS OF THE SON
OF SEVENLESS PROTEIN
Linda S. McCollam
University of Massachusetts Graduate School
of Biomedical Sciences
1998
The questions outlined in this thesis dissertation were proposed in
order to provide insight regarding the mechanism by which the Drosophila
Son of sevenless (dSOS) protein activates Ras. Ras proteins are GTP-
binding proteins which bind guanine nucleotides ' very tightly and cycle
between the inactive GDP-bound state and the active GTP-bound state. To
address the mechanism by which the dSOS proteins activates Ras , a
structure-function analysis of the dSOS protein was performed using
truncation and deletion mutants of dSOS. In vivo Ras activation
experiments using transiently transfected cells revealed that the NH
terminal domain of dSOS is required in order for the catalytic domain of
dSOS to exhibit exchange activity in cultured mammalian cells. The
COOH-terminal GRB2 (Growth Factor Receptor Binding Protein) binding
domain on the otherhand was insufficient to confer Ras exchange activity to
the dSOS catalytic domain. Further analysis of the NH terminal domain of
the dSOS protein demonstrated that the function of promoting catalytic
domain activity could be localized by mutational analysis to the pleckstrin
(PH) and DBL (Diffuse B-cell Lymphoma) homology sequences.
Fractionation studies of -cells transiently transfected with various dSOS
mutant proteins demonstrated that the NH terminus of dSOS is also
necessary for membrane association. These findings suggested that the
model proposing that the recruitment of SOS via the adaptor protein GRB2
to the membrane is the main mechanism by which SOS activates Ras is
unlikely to be the only mechanism by which SOS can activate Ras. From
our data, a model can be proposed which postulates that SOS can activate
Ras as a consequence of at least two steps. One step involves the SOS/GRB2
interaction and the second step involves the NH terminal domain of SOS
associating with unidentified cellular elements.
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CHAPTER I
BACKGROUND
A. Ras superfamily
The Ras superfamily comprises over 60 small guanine nucleotide
binding proteins that regulate a diverse aray of biological functions (1,2).
The molecular weight of these guanine nucleotide binding proteins ranges
from 20-25 kDa. Based on primary amino acid sequence, the proteins are
divided into subfamilies designated Ran , Rab , Rho, Ar, and Ras (1,2).
Specifically, certain members of the Ras subfamily have been shown to be
important in cell proliferation and differentiation (1-4). Ran has been
implicated to playa role in nuclear functions such as nuclear transport (1-
5). There is evidence that Rab and Arf proteins play an important role
in intracellular vesicular transport (1- 7). The Rho subfamily regulates
cytoskeletal organization, for example , membrane ruffling (1- 9) and
generation of the superoxide free radical in NADPH oxidase catalyzed
reactions (1- 10). All members of the Ras superfamily have the ability to
cycle between the active GTP-bound state and the inactive GDP-bound state
(Figure 1). The proteins become biologically active when GDP is released
and replaced with GTP. The intrinsic rate of this exchange is extremely
slow. Ras superfamily proteins are regulated by the rate . at which they
hydrolyze bound GTP and the rate at which they exchange GDP for GTP.
Negative regulatory proteins referred to as GTPase activating proteins
(GAPs) catalyze the hydrolysis of GTP to GDP, thus leading to inactivation
of the Ras superfamily proteins (11,12). Positive regulatory proteins
referred to as guanine nucleotide exchange factors (GNEFs) accelerate the
exchange step by interacting with members of the Ras superfamily (12,13).
In addition , Rho and Rab proteins interact with yet a third class of
regulatory proteins referred to as guanine nucleotide dissociation inhibitors
(GDls). GDIs interact with GTPases to maintain' the nucleotide bound state
(14 15).
B. Ras subfamily
Ras proteins are present in all eukaryotic organisms from human to
yeast. Ras was originally identified 15 years ago in animal tumor viruses
containing the activated allele of the ras gene which is referred to as the
oncogene. There are three human ras genes which encode four Ras
(GAP 
IRAS'GDP 
(Inactive)
(Active)
Figure 1. The GTPase Cycle. Ras superfamily proteins
cycle between the active GTP-bound and inactive GDP-
bound states as a consequence of the actions of GAPs
(GTPase activating proteins) and GNEFs (Guanine
;i,
Nucleotide Exchange Factors).
proteins: H-ras (Harvey), K-ras4a (Kirsten), K-ras4B , and N-ras.
Specific point mutations in these three ras genes have been found in thirty
percent of human tumors (3). The glycine at position 12 seems to be the
most frequently mutated residue in Ras , and amino acids 13 and 61 have
also been found to be mutated in mammalian Ras. Mutations at these three
positions in Ras have been demonstrated to cause a ten-fold decrease in the
intrinsic hydrolysis rate of GTP.
Ras proteins have a molecular weight of 21 kDa. Primary sequence
elements which dictate guanine nucleotide binding and are conserved in all
proteins that comprise the Ras superfamily are found in Ras at the
following positions: amno acids 10- 16, GXXXXGK; amino acids 57-162
DXXGXE; amino acids 116- 119 , NKXD; and amino acids 143- 147
EXSAX (2). Additionally, primary sequence analysis reveals another
conserved region in Ras proteins referred to as the effector domain at
position amino acids 32-40. Mutations in this region (amino acids 32-40)
caused no change in the ability of Ras proteins to bind and hydrolyze GTP.
However, these mutations eliminated the ability of Ras proteins to
transform (16). Therefore , this region seems to be important in the
interaction of Ras with cellular targets. Further experiments demonstrated
that the effector domain does bind other proteins, for example GAP
proteins , which will be discussed in a later section in more detaiL
Ras proteins are posttranslationally modified. Ras proteins possess the
conserved CAAX box at the C-terminus. The cysteine in this box is
farnesylated via a thioether linkage by a faresyl-protein transferase. The
three C-terminal amino acids are then proteolytic ally cleaved , and the C-
terminus is carboxymethylated. Finally, Ras proteins are palmitoylated on
cysteine residues within the C-terminal hypervariable region. As a result
Ras becomes associated with the inner side of plasma membranes where it
can participate in signaling cascades. In addition, K-RAS4B requires a
polybasic domain of six consecutive lysine residues located within the
hypervariable region in order to have efficient plasma membrane
targeting.
C. Receptor Tyrosine Kinases
The binding of polypeptide growth factors or hormones to receptor
tyrosine kinases present on the surface of cells initiates a cascade of
signaling events that are important in cellular regulation. Receptor
tyrosine kinases generally consists of five major structural domains: 1.) the
extracellular domain is responsible for binding the growth factor or
hormone and for subsequent transmission of the signal; 2.) the
hydrophobic transmembrane domain is responsible for connecting the
extracellular and intracellular domains; 3.) the juxtamembrane domain
connects the transmembrane and kinase domains; 4.) the tyrosine kinase
domain consist of two conserved structural motifs , an A TP-binding site
(lysine residue and GXGXXG consensus sequence) and a tyrosine residue
which can accept the y phosphate from A TP; and 5.) the carboxyl-
terminal domain consists of two possible regulatory domains ( C- terminal
tailor kinase inserts) both of which contain many autophosphorylation sites
(17,18).
Mammalian cells contain several receptor tyrosine kinases all of which
comprise the conserved catalytic core and diverse regulatory sequences.
Analysis of the primary amino acid sequence of receptor tyrosine kinases
suggest that they fall in two main categories , based on similar structural
motifs (see Figure 2). Receptors in the first category contain cysteine-rich
regions in the extracellular domain and an uninterrpted kinase domain.
One group of receptors in this category is the EGF-R family which consist
of two cysteine-rich domains (19). A second group of
EGF
RECEPTOR
INSULIN
RECEPTOR
8- 8-
PDGF
RECEPTOR
receptors , in this category, consist of disulfide-linked heterotetramers (2ex
and 2~ subunits) and a single cysteine-rich domain, for example , IR
(20,21), IGF- 1R (22), and c-met receptor (23). The second category of
receptors encompasses those which have more regularly spaced cysteines
and a varying number of immunoglobulin- like domains. In addition, a
regulatory domain is inserted into the conserved kinase domain. Examples
of receptor tyrosine kinases in this category include PDGF-R (24), CSF-
R (25), c-kit (26), and FGF-R (27).
Although the above mentioned receptor tyrosine kinases are structurally
distinct, the early events following their respective ligand binding appear
mechanistically similar. The tyrosine kinase is a tivated, and the receptor
undergoes autophosphorylation on specific tyrosine residues located in the
kinase domain. This activation of the kinase results from a conformational
change caused by receptor oligomerization or receptor phosphorylation.
Once the kinase is activated the receptor can then phosphorylate a variety of
intracellular substrates. These substrates are proteins containing elements
that bind the phosphotyrosine residues present on the intracellular domains
of the activated receptors. Protein regions that bind phosphorylated
tyrosine residues are either SRC homology-2 domains (SH2 domains) or
phosphotyrosine-binding domains referred to as PTB domains.
SH2 domains consist of approximately 100 amino acids that are
conserved in a wide variety of signaling molecules (28-31). Cantley et aI.
have illustrated that high affinity binding of SH2 domains to
phosphotyrosine residues requires that the phosphorylated tyrosine residue
be within a specific amino acid sequence context (32-34). For example , the
SH2 domains of GAP, PLCy, and PI3K recognize distinct
autophosphorylated phosphotyrosine residues on the ~ receptor for PDGF
(35-41). SH2 domains are found in proteins with a known catalytic domain
and also in proteins without a catalytic domain. Examples of SH2-containing
proteins with a catalytic domain are SRC (tyrosine kinase), ABL (tyrosine
kinase), SYK (tyrosine kinase), PTP1C (phosphotyrosine phosphatase),
PLCy (phospholipase C), and GAP (42). SH2-domain containing proteins
without a catalytic domain are referred to as adapter proteins. These
proteins which include p85 , SHC, c-CRK, NCK, and GRB2 , are responsible
for coupling tyrosine kinase activity to downstream targets. SH2 domains
rely on amino acids carboxy-terminal to the phosphotyrosine for specific
recognition.
PTB domains also bind specifically to phosphotyrosine containing
peptides. However, specificity is achieved in a different manner than with
SH2 domains. The PTB domain was first identified in the SHC protein
(202 203) and subsequently found in several other signaling proteins
including IRS- 1 (204). Unlike SH2 domains , PTB domains rely on amino
acids amino-terminal to the phosphotyrosine for specificity (204).
Structural studies revealed that PTB domains share a common fold. More
specifically, the PTB domains of SHC and IRS- 1 share a related structure
and the general orientation for peptide binding to the two PTB domains is
similar. Interestingly, the PTB domains of SHC and IRS- 1 share little
sequence homology, and residues contacting the phosphotyrosine are
different in the two domains (204 216).
Several SH2-containing proteins possess a second protein-protein
interaction domain, which has been designated the SH3 domain. SH3
domains consist of approximately 50 amino acids , and they are present in a
wide variety of signaling proteins and cytoskeletal elements. The interaction
of the SH3 domain of ABL and the ABL binding proteins 3BP- 1 and 3BP-
was demonstrated by Cicchetti et at. using AGT11 expression cloning
(43 44). The crystal structures of the SH3 domain of spectrin, fyn, and 1ck
have been determined by X-ray crystallography (45,46). In addition, the
crystal structures of the SH3 domains of the SRC tyrosine kinase , PLCy, and
p85 have been determined by NMR(47,48). These studies have revealed
that SH3 domains consist of two 3-stranded antiparallel ~-sheets , and that
the interface of these sheets forms a hydrophobic core (45). Furthermore
NMR studies of SRC bound to proline-rich peptides derived from 3BP-
sequences indicate that the amino acid sequence PPPLPP interacted
specifically with SH3 domains (48-50). Several in vitro studies later
confirmed that SH3 domains bind the motif PPPXPP. For example, the SH3
domains of GRB2 were shown to bind to proline-rich sequences in the
guanine nucleotide exchange factor Son-of-Sevenless (51 52). The functional
importance of SH3 domains was evident from mutational studies performed
by Kato et aI. and others which revealed that deletions and/or substitutions
of amino acids in SH3 domain of SRC increased both its catalytic activity
and oncogenic potential (53-56). In addition, th se mutants failed to bind
plIO, a known substrate of SRC (57). Hence, SH3 domains and SH2
domains both seem to be important in regulating protein-protein
interactions in signal transduction via receptor tyrosine kinases.
D. Role of Ras in Signaling by RTK
Over the past ten years , evidence has accumulated that clearly
demonstrates the role of Ras as a downstream component in signaling
pathways from transmembrane receptors. The Ras signaling pathway
modulates important cellular processes such as transcription and protein
synthesis (58-65). These transmembrane receptors are tyrosine kinases , or
transmembrane receptors associated with tyrosine kinases , or receptors
coupled to heterotrimeric G-proteins. Depending on the type of cell and
receptor, Ras signaling- can mediate either differentiation or proliferation
66-67). Stimulation of receptors by ligand results in activation of
guanine nucleotide exchange factors , and as a result accumulation of Ras-
GTP. Subsequent to Ras activation there are increases in protein
phosphorylation, phospholipid metabolism, and transcriptional activity. Ras
genes are evolutionarily conserved, and thus Ras proteins seem to function
as a universal relay in cell signaling.
Initial insight into the Ras signaling pathway was provided by genetic
studies with the budding yeast S. cerevisiae. Two Ras proteins exist in the
budding yeast, Ras1 and Ras2 , and both seem to regulate adenyl ate cyclase.
Nutritional signals initiate the activation of Ras by the guanine nucleotide
exchange factor Cdc25 which catalyzes the exchange of GDP for GTP on
Ras. Activated Ras stimulates adenylate cyclase resulting in increased levels
of cAMP. The cAMP dependent protein kinases , (TPK1 , 2 3), then
regulate cell growth and cell division by directly phosphorylating multiple
protein substrates (68-70). The action of these kinases is to prevent cell
division by inhibiting transcription of Cln1 and Cln2 G 1 cyc1ins and to
promote cell growth by removing transcriptional repression which allows
the cell to proceed from G 1 to S phase once it has achieved a critical mass.
As understanding of the steps in the Ras signaling pathway in the budding
yeast increased, it became clear that mammalian Ras functions differently
from Ras in budding yeast. Beckner et aI. showed that mammalian Ras does
not stimulate adenyl ate cyclase (71). Thus , the key question still remained
What is the function of Ras in mammalian cells?"
Biochemical and genetic studies using mammalian cells Caenorhabditis
elegans and Drosophila melanogaster have demonstrated that Ras is a
critical downstream component of receptor tyrosine kinase mediated
pathways. Mulcahy et at. demonstrated that microinjection of anti-Ras
antibodies into mammalian fibroblasts caused the cells to become refractory
in their response to serum and growth factors (72). In addition
microinjection experiments using dominant negative mutants of Ras were
shown to : 1.) block Ras function in fibroblasts (73 74), 2. ) block NGF-
induced differentiation of neuronal PC12 cells (75), and 3.) block insulin-
induced maturation of oocytes (76). In the same manner, oncogenic Ras
genes were shown to induce NGF-independent differentiation of PC12 cells
and growth factor independent proliferation in fibroblasts (77). Several
studies have revealed that stimulation of cells with growth factors such as
EGF, PDGF, insulin , NGF, and M-CSF results in the accumulation of the
active GTP-bound form of Ras (67 78-84). Activated Ras is then able to
interact with effector molecules to initiate downstream signaling pathways
, the Ras activated mitogenic pathway. The serine/threonine protein
kinase Raf directly associates with Ras-GTP, resulting in the translocation of
Raf to the plasma membrane where it becomes activated (85 86). This
activation of Raf results in the initiation of a kinase cascade. MAPK kinase
the direct substrate for Ras becomes activated and in turn activates MAP
kinase, several isoforms of which have been described (64 87). Activated
MAP kinase subsequently translocates to the nucleus where it phosphorylates
and activates transcription factors resulting in the induction of gene
expression via Ras responsive elements. Several substrates for MAP
kinases , including p90 ribosomal S6 kinase, cPLAz, PHAS- , c- MYC , and
ELK have been described (64 87-88). Ras therefore seems to be a key
player in regulating diverse signaling pathways between cell surface
tyrosine kinase receptors and the activation of transcription in the nucleus.
Functional similarities exist between mammalian Ras and Ras from both
Caenorhabditis elegans and Drosophila melanogaster. In C. elegans Ras
functions downstream of the receptor tyrosine kinase LET- , a member of
the EGFR family, to control the differentiation of specific ectodermal
precursor cells to a vulval rather than an epidermal fate (90). Genetic
experiments have identified the components downstream of Ras in this
pathway: lin-45 (Raf homologue), mpk- l/sur- 1 (MAPK), and transcription
factors such as lin- 31. In Drosophila genetic experiments have
demonstrated that Ras paricipates in three receptor tyrosine kinase
signaling pathways which regulate different aspects of development: 1.
sev-sevenless tyrosine kinase receptor; 2. ) tor-torso tyrosine kinase
receptor; and 3. ) the DER- Drosophila EGFR (89). Specifically, Sev
regulates the fate of the R7 photoreceptor precursor cell in each eye
ommatidum. Differentiation of the tail and unsegmented head regions
during embryogenesis requires activation of tor dependent kinase cascade
(89). Lastly, DER tyrosine kinase receptor has been implicated to playa
key role in multiple developmental steps (89).
E. Ras Effectors
Over the past several years , data has emerged which suggests that Ras
has multiple effectors, molecules which preferentially bind to GTP-bound
Ras. Three-dimensional structural studies of Ras have shown that when Ras
undergoes transition from its GTP-bound state to its GDP-bound state
conformational changes occur in two regions. These two regions are
referred to as Switch I (residues 30-37), which overlaps the effector
domain, and Switch II (residues 60-76). Three specific amino acids (Tyr
, Thr 35 , and Gly 60) found within these two regions are conserved in all
GTP-binding proteins (91 92). Studies indicate that these residues are
involved in binding the y-phosphate of GTP, and thus they play an
important role in the GTP-dependent mechanism which modulates the
interaction of Ras with specific effectors.
Three standard methods have been applied to identify Ras effector
molecules: 1.) the yeast two-hybrid system; 2. ) GST-fusion assays using
purified GST-Ras-GTP and cell extracts; 3.) a method of genetic screening
in S. cerevisiae which identifies proteins that inhibit Ras-dependent
activation of adenylate cyclase. Identification of Ras effector molecules is
integral to understanding how Ras proteins function.
The first vertebrate proteins identified to associate preferentially with
Ras-GTP were the GAPs. GAPs negatively regulate the Ras signaling
pathway by accelerating the intrinsic Ras GTPase activity. GAP has a
molecular weight of 120 kDA. The amino-terminus of GAP consists of two
SH2 domains and one SH3 domain. Experiments suggest that GAP is not
normally a mitogenic target of Ras. For example , mutations within the Ras
effector loop inhibit the interaction of GAP with Ras-GTP, yet mitogenic
signaling is retained (93). However, other studies indicate that mitogenic
signaling can occur via the amino-termnal domain of GAP. Specifically,
microinjection into Xenopus oocytes of antibodies raised against the SH3
domain of GAP prevents Ras-dependent germinal vesicle breakdown (94).
Additionally, overexpression of the amino-terminus of GAP results in Ras-
dependent transcription from the fos promoter (95). DeClue and coworkers
have shown that cotransfection of the amino-terminus of GAP and v-Src
results in the transformation of NIH3T3 cells (96). Mattingly et al.
demonstrated that overexpression of the SH3 domain of GAP in NIH3T3
cells inhibits muscarinic stimulated Ras activation (97).
Two proteins have been identified, p62 and p 190, which associate with
GAP via its amino-terminus in growth factor stimulated cells (98). The
p62 protein is a cytoplasmic protein with RNA binding capability, and it has
been shown to interact with GRB2 , PLCy, and Src family kinases (99). The
p 190 protein possesses GAP activity for the mammalian Rho protein, and is
able to bind guanine nucleotides (100). In order to elucidate exactly how
GAP serves as an effector for Ras , precise functional roles for p62 and
p 190 need to be defined.
Although several putative effectors for Ras have been delineated, only
one such protein, Raf, has been clearly established as a Ras target protein in
mitogenic and developmental signaling. Raf a serine/threonine kinase, exists
as three separate isoforms, c-Raf- , B-Raf, and A-Raf. A vast body of data
has been generated which implicates association of Ras with Raf. In vitro
studies performed by Moodie and coworkers initially demonstrated the
association of Raf with GTP bound Ras (101). Subsequently, the yeast two-
hybrid system was applied to confirm this interaction and to demonstrate
that the Ras binding domain in Raf consists of residues 51- 131(102). Vojtek
and coworkers utilizing various cDNA expression libraries isolated proteins
that bind to Ras-GTP (103). They succeeded in isolating a fragment of Raf
which corresponds to its regulatory domain. Subsequently, several groups
have demonstrated the ability of recombinant Ras to bind to the regulatory
domain of Raf in vitro , and mutations in the Ras effector region seem to
block this interaction (104,105). Ras recruits Raf to the plasma membrane
and other proteins have been suggested to participate in the recruitment of
Raf to the plasma membrane. This recruitment, as well as the association of
Raf with Ras-GTP, and the phosphorylation of Raf, all seem to contribute
to the activation of Raf.
Zhang et at. utilizing the yeast two-hybrid system to identify proteins
which bind Raf, isolated a Ras-related protein called RaplA (104). Rap1A
is a homologue of Ras in the sense that it has the same core effector region.
X-ray crystallography was used to generate the three-dimensional structure
of the complex of Rap1A with the Ras binding domain of Raf (106). The
structure revealed that Rap and Raf interact via an inter-protein ~-sheet
which is formed by two anti-parallel strands from the two proteins (106).
These structural studies also confirmed that residues that were predicted to
be involved in effector binding were indeed located at this interface and
involved in binding.
Other putative Ras effectors include PI3K and MEK kinase- 1(MEKK1).
PI3K is an enzyme which phosphorylates phosphotidylinositol at the D-
position on the inositol ring. PI3K consists of two subunits , the p110
catalytic subunit and the p85 regulatory subunit. The regulatory subunit
consists of one SH3 domain, two SH2 domains, and a Rho-GAP domain.
While the majority of published data suggests that PI3K acts upstream or
independently of Ras (107), some evidence exists to suggest that PI3K is
downstream of Ras. Sjolander and coworkers detected PI3K activity in Ras
immunoprecipitates of both Ras transformed and agonist treated cells (108).
Subsequently, Rodriguez- Viciana et at. demonstrated in vitro binding of
Ras-GTP and plIO , and that this association requires an intact effector loop
(109, 110). In addition, these studies provided evidence that this Ras-GTP
interaction occurs in vivo and might contribute to the regulation of p110.
Specifically, it was demonstrated that expression of the N17 Ras dominant
inhibitory mutant in PC12 cells blocks NGF induced production of
PI(3,4)P and PI(3 5)P . Furthermore, coexpression of p85 , plIO , and
Ras in COS cells resulted in increased PI(3,4)P and PI(3,4,5)P while in
contrast expression of Raf, Rho , Rac(V12), or Ras(A38) together with p85
and plIO induced an increase in PI3K activity.
The role of MEKK - 1 as a Ras effector molecule has not been studied as
extensively as PI3K. MEKK- 1 is an upstream r gulator of the Jun nuclear
kinases (JNKs). JNK kinases are also referred to as stress activated protein
kinases (SAPKs). The SAPKs are related to the MAPK family however
they are activated by different extracellular stimuli (111- 113). JNKs
increase transcriptional activity of target genes by regulating the activity of
Jun and ATF2 via phosphorylation. In 1995 Russell and coworkers
initially demonstrated that MEKK- 1 associates with Ras-GTP in vitro (114).
The kinase domain of MEKK1 was shown to bind to GST-Ras(V12) in a
GTPdependent manner, and this association could be disrupted by the
addition of an effector domain peptide derived from the Ras effector
sequence. The relevance of the MEKK - 1/ Ras interaction in vivo needs to
be studied further to understand the role of MEKK - 1 in Ras signaling.
PKCS has also been postulated to be a Ras effector protein. PKCS is 
protein kinase C that is unique in the sense that it is neither Ca +2 dependent
nor responsive to phorbol esters (115 116). It has been demonstrated that
PI(3 5)P can activate PKCS in vitro (117). Putative substrates of PKCS
are MEK1 , MEK2 , and IKB (I kappa B-alpha) kinase (118 119). Initial
studies in Xenopus oocytes illustrated that PKCS is necessary for Ras
dependent maturation (120). Diaz-Meco and coworkers
coimmunoprecipitated Ras and PKCS from PDGF treated NIH3T3 cells
while expression of the N17 dominant inhibitory Ras mutant inhibited
PDGF stimulated PKCS activity (120). They also demonstrated that PKCS
associates with Ras-GTP in vitro. Further studies need to be performed in
order to determine if PKCS is truly a Ras effector.
F. Ras Activators
As described previously, GAP was the first regulator identified for the
Ras proteins. The fact that Ras has both a low intrinsic GDP/GTP exchange
rate and a negative regulator, GAP, suggests a fixed rate of accumulation of
inactive Ras. Therefore, it was predicted that positive regulators of Ras
proteins must exist in order to accelerate this low intrinsic exchange rate.
The identification of guanine nucleotide exchange factors (GNEF) has been
an important step in understanding how Ras proteins are activated. Since
Ras proteins are conserved in lower eukarotes , yeast genetics were initially
used to identify the GNEF, Cdc25. Broek and coworkers succeeded in
isolating the gene corresponding to the S. cerevisiae cell division cycle
mutant cdc25 (121). The cdc25 temperature sensitive mutant was shown to
cause G 1 arrest at the non-permissive temperature. This temperature
sensitive mutation can be suppressed by either the presence of a high copy
number plasmid carrying the gene coding for an active cAMP-dependent
protein kinase (Tpk1 , Tpk2 , or Tpk3), or by the presence of constitutively
active Ras or adenylyl cyclase (121,122). Initial genetic data suggested that
Cdc25 regulates Ras and is required for its activation. Subsequent
biochemical data confirmed that the Cdc25 gene product promotes the
release of guanine nucleotide bound to yeast Ras and mammalian Ras (123).
The Cdc25 protein has a molecular weight of - 180 kDa. In vitro studies
demonstrated that the catalytic domain of Cdc25 is approximately 450
amino acids (124). Three additional yeast proteins that share homology
with Cdc25 have been isolated, Sdc25 (125) and Bud5 (126 127) from S.
cerevlszae and Ste6 from S. pombe (128). Sdc25 and Ste6 have been shown
to be Ras-specific GNEF's however. Experimental evidence suggests that
Bud5 is a GNEF for the Rsrl protein, a member of the Ras subfamily of
GTPases , and that it is involved in the control of bud site localization in the
yeast S. cerevisiae (129.).
In 1990, four papers were published that initially identified a nucleotide
exchange promoting activity forRas in mammalian cells (130- 133). In
1992 several groups began to attempt to isolate mammalian homologues of
the yeast exchange factor. Figure illustrates proteins that share
homology with the catalytic domain of Cdc25 , and thus function as guanine
nucleotide exchange factors for Ras. Utilizing a method of genetic
complementation of the temperature sensitive cdc25 strain, Martengani
and coworkers succeeded in isolating a partial cDNA from a mouse brain
cDNA library which they referred to as CDC25Mm/RAsGRF. In vitro studies
confirmed that Cdc25 Mm was able to activate adenylyl cyclase in a Ras2-
dependent manner (134). This brain specific Cdc25 homologue was
demonstrated to activate Ras both in vivo and in vitro (135). Northern blot
analysis revealed the presence of the Cdc25 homologue in mouse hear and
to a small extent in liver and spleen (134). Hui Cen et at. subsequently
screened a mouse brain cDNA library and identified several full length
clones of Cdc25 Mm (136). Additionally, degenerate oligonucleotides
designed to code for all peptides present in two highly conserved regions of
Cdc25 , Sdc25 , and Ste6 were utilized as a method to clone mammalian
homologues of Cdc25. Thus , Shou et at. cloned a cDNA from a rat brain
library which encodes p140 Ras-GRF, a 140 kDa guanine nucleotide releasing
factor for Ras which contains the Cdc25 catalytic domain. The Cdc25
homology domain of Ras-GRF was able to catalyze the release of GDP
from Ras in vitro, but not the release of GDP from RalA (Ras related
protein) or Cdc42Hs , suggesting that the p140 Ras-GRF is a guanine
nucleotide releasing factor specific for Ras (137). Two groups have also
succeeded in isolating homologues of Ras-GRF from human brain cDNA
libraries (138, 139).
Concurrently, the son of sevenless (SOS) gene was isolated and shown
to encode a Drosophila homologue of Cdc25. Genetic experiments in
Drosophila first demonstrated that the sos gene functions in a signal
transduction pathway downstream of the sevenless receptor tyrosine kinase
and the EGFR (140- 142). The sos gene was first described as a dominant
mutant allele referred to as SOSJcz. Bonfini and coworkers isolated and
characterized the sos gene which coded for a protein with a molecular
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Figure 3. Proteins with homology to yeast CDC25 protein
catalytic domain. Functional domains are denoted as follows:
, CDC25 homology; II , PH domain; II , Proline-
rich regions; , Dbl homology; and a, SH3 domain d 3).
weight of -180 kDa (143). Sequence analysis revealed that SOS protein
contained a region which was 45% identical and 70% similar to the Cdc25
catalytic domain suggesting that the sos gene product is an exchange factor
for Drosophila Ras. Therefore, SOS seems to playa key role upstream of
Ras in the sevenless receptor tyrosine kinase cascade leading to Drosophila
eye development.
Several months later, mammalian homologues of the Drosophila sos
gene were isolated. Bowtell et at. screened a mouse cDNA library under
low stringency using the Drosophila sos gene as a probe (144). Two
mouse genes were isolated in this manner and referred to as mSOS 1 and
mSOS2. Primary sequence analysis showed that mSOS 1 and mSOS2 share
an overall 45% amino acid identity with the Drosophila SOS protein. The
predicted molecular weight of these proteins is - 150 kDa. Unlike the brain
specific Ras-GRF/ Cdc25 , northern blot analysis demonstrated that the
two mouse sos genes are widely expressed both during development and in
adult tissues. Subsequent genetic studies illustrated that the mSOS 
catalytic domain was able to suppress the loss of Cdc25 function in 
cerevisiae (145).
Furthermore, in vitro studies demonstrated that the GST -SOS 1
catalytic domain is able to bind to the nucleotide free form of Ras
, (145) in
a manner similar to that previously demonstrated for the yeast Cdc25
protein (124). The GST-SOS1 catalytic domain was also .shown to catalyze
guanine nucleotide exchange on Ras in vitro , but only in the presence of an
excess of free guanine nucleotide (145). These data suggest that SOS
recognizes nucleotide-free Ras as a reaction intermediate and Ras-GTP as a
product.
Pierre Chardin and coworkers later succeeded in isolating the human
SOSl and SOS2 genes. They screened a rat brain cDNA library using
degenerate oligonucleotides that were designed to code for all peptides
present in two highly conserved regions of Cdc25 , Sdc25 , Ste6 , and
Drosophila SOS (146). Two distinct clones were isolated which were then
used as probes to screen two human fetal brain cDNA librares and a
human skeletal muscle cDNA library. Two cDNAs were isolated and
identified as hSOS 1 and hSOS2, and share 69% overall amino acid identity
(146). The predicted molecular weight of these proteins is approximately
150 kDa. As described previously for mSOS1 , the hSOS1 catalytic domain
was also able to complement the loss of Cdc25 in yeast (146). These
studies also demonstrated that hSOS 1 catalytic domain can activate Ras in
vitro , and overexpression of full length hSOS 1 in human kidney 293 cells
resulted in an increase in guanine nucleotide exchange activity in cell
extracts (146). Thus , these experiments suggested that hSOS1 is a guanine
nucleotide exchange factor for Ras. The key question still remained
, "
Are
SOS proteins the major activators of Ras in vivo?" Recent published
results demonstrated a specific requirement for mSOS 1 in the EGF
receptor signaling cascade in vivo. Genetic experiments were used to show
that disruption of the msos 1 gene resulted in a defective MAPK activation
in response to EGF(147). In addition, these experiments illustrated a
strong genetic interaction between a weak allele of the EGF receptor and a
heterozygous msos1 mutation (147).
Another protein referred to as C3G (CRK-SH3 binding protein) was
identified as a mammalian GNEF. CRK, like GRB2 , is an adapter protein
consisting of only SH2 and SH3 domains. Sequence analysis of C3G
revealed that C3G has the conserved Cdc25 homology domain at its
carboxy terminus (148). Antibodies against C3G recognize a protein with
an apparent molecular weight of 140 kDa that is widely expressed in
human adult and fetal tissues. Like SOS , C3G is also able to suppress the
loss of Cdc25 function in the yeast S. cerevisiae (148). Initially, it was
thought that C3G was an activator for Ras. However, the substrate
specificity of C3G was examined by Gotoh et at. and results clearly
demonstrated that C3G is a Rap 1 activator. Rap 1 is a member of the Ras
subfamily and has the same core effector region as Ras , but its function is
still elusive. Recent studies have revealed that Rap1 is activated in human
platelets and neutrophils in response to varous agonists suggesting that
Rap 1 may playa role in one of the specialized functions of these cells. 
vitro studies showed that C3G could stimulate the dissociation of GDP
from Rap1 to a large extent but, had little effect on the dissociation of GDP
from Ras or RAL (149 150). Coexpression of C3G and Rap1 in COS7
cells results in an increase in the amount of GTP bound to Rap 1 whereas
SOSl is unable to activate Rap1 (151).
Recently, a mammalian GNEF with homology to Ras-GRF, SOS, and
Cdc25 was cloned and characterized from a mo se brain cDNA library,
and this cDNA is referred to as Ras-GRF2 (152). Ras-GRF2 seems to be
widely expressed based on northern blot analysis. The predicted molecular
weight of Ras-GRF2 is - 135 kDa. In vitro studies confirmed that Ras-
GRF2 functions as a Ras-specific GNEF (152). In addition as described for
GRF1 (152) expression of Ras-GRF2 in kidney epithelial cells results in the
activation of Ras and activation of ERK1 in response to elevated
intracellular calcium levels (152). Future experiments will determine what
specific extracellular signals are responsible for the activation of Ras-
GRF2.
The mammalian Ras- GRF proteins and the Drosophila and mammalian
SOS proteins possess two additional important homology domains. These
two domains are arranged in tandem (Figure 4) and are designated the
DBL homology (DH) domain and the pleckstrin homology domain (PH).
The DBL homology domain consist of -250 amino acids subdivided into
three conserved regions (153,154). DBL is a protein which was initially
isolated from a diffuse B-celllymphoma (155). DBL shares homology
with the S. cerevisiae cell division cycle protein Cdc24. Cdc24 acts
together with the Ras-like GTP binding protein Cdc42 to regulate bud site
assembly in yeast (156). Studies performed by Hart and coworkers
demonstrated that baculovirus expressed DBL catalyzes the dissociation of
GDP from human Cdc42 protein (157). More specifically, amino acids
640-646 (LLKELL), which are very highly conserved, appear to be
required to catalyze GTP loading of Rho-like GTP binding proteins (157).
The DBL homology region of SOS and Ras-GRF proteins represents only a
small portion of the regions in Cdc24 and DBL (136), but this region
appears to be required in all cases to catalyze GTP loading of Rho- like
GTP-binding proteins. The degree of sequence similarity between the
DBL homology domains in SOS/GRF proteins is somewhat low
approximately 30 %. There is no evidence thus far to suggest that SOS or
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Figure 4. Domains of the Sos Of Sevenless protein. The dSOS
protein can be divided into three major domains: 1.) the amino-
terminal domain (NH2 domain), 2. ) the catalytic domain, and 3.) the
carboxyl-termnal domain (COOH-domain). The NH2-terminal
domain contains the PH and the DBL homology regions. The COOH-
terminal domain contains proline-rich motifs which are responsible for
binding the adaptor protein GRB2. The amino acid numbers are
denoted beneath the dSOS construct.
Ras-GRF proteins are able to act as activators for the Rho family proteins.
However, the presence of two separate catalytic domain similarities (Cdc25
and DBL) in these guanine nucleotide exchange factors suggest that by
some mechanism they may be able to coordinately regulate the activities of
Ras and Rho family proteins.
The second mentioned homology domain common to all DBL family
proteins is referred to as the PH domain. The PH domain was originally
identified as a protein module of - 120 amino acids that shares homology
with two regions of the protein pleckstrin. Pleckstrin is a protein which is
the major substrate for ser/thr phosphorylation by PKC in platelets. The
PH domain is present in a variety of intracellular signaling and
cytoskeletal proteins. The PH domain was proposed to be involved in
protein-protein interactions. More then 90 PH domain-containing proteins
have been identified, including ser/thr kinases , tyrosine kinases , isoforms
of phospholipase C , GAP' , GNEF' , and cytoskeletal elements (158).
There is only one invariant amino acid in all PH domain-containing
proteins , which is a conserved tryptophan near the carboxy terminus. The
three-dimensional structure of the PH domains from pleckstrin (159),
spectrin (160), dynamin (161- 163), and SOS (164) have been determined
by NMR and or X-ray crystallography analysis. Although the overall
homology shared among PH domains is low , all three structures show a
common fold consisting of two orthogonal ~-sheets which form a sandwich
that is capped by the C-terminal a-helix at one end (165). The invariant
tryptophan is found within the helix. It is noteworthy to mention that more
recent structural studies .of phosphotyrosine recognition sites (PTB
domains) found in proteins such as IRS- 1 and SHC illustrate that they share
a common fold with PH domains (204). Thus , it was predicted that PH
and PTB domains serve to recruit proteins close to the membrane surface
where they can interact with their target proteins.
The structures revealed that there is a potential for a cluster of
positively charged amino acids to form on the fa e of the molecule opposite
from the C-terminal a-helix. This suggested that PH domains may interact
with membrane surfaces via binding negatively charged phospholipids. 
support of this , Hyvonen et at. performed structural studies that
demonstrated the binding of Ins(1,4,5)P to the PH domain of mouse
spectrin (166). In addition, the PH domains of pleckstrin , T-cell specific
kinase , rasGAP, and ~ARK were found to bind PI(4 5)P (167). Mutational
studies of the PH domain of pleckstrin indicated that three specific lysine
residues (positions 13, 14, and 22) are important for binding PIPz in vitro
(168). PIP binds to the PH domains of pleckstrin and spectrin with
relatively low affinity (Kd- 30 flM) (166, 168). By contrast, the PH
domain of PLC8 binds PIPz with relatively high affinity (Kd- 1.7 flM). PI-
binding to the PH domain of PLC8 seems to playa role in recruiting
PLC8 to the membrane (165). Very recently, Kubiseski and coworkers
demonstrated utilizing lipid vesicles containing PI- z, that PIPz binds
with relatively high affinity (K 8 flM) to the PH domain of mSOS 
(169, 170). More specifically, these studies demonstrated that a specific
amino acid within the PH domain of mSOS1 , Arg , plays a critical role in
mediating this interaction with PIP (169). All of these lipid binding
studies are in vitro studies and further experimentation is required to
determne if this interaction of PH domains with "PIPz plays an important
role in regulation of these proteins in vivo.
Recently, the ability of various PH domains to bind to products of PI3-
kinase has been investigated by several groups. PI-3,4- and PI-3,4,
could provide one possible mechanism for regulated recruitment of
proteins to the membrane since both of these lipids are produced in
response to cell stimulation (210). PI- and PI- P on the other hand
are constitutively produced in cells (210). Initial studies of the PH domain
in Akt the Ser/Thr kinase , suggest PI-3,4- binds selectively to the PH
domain and that PI-3,4- z activates the kinase (208,209). In addition, the
PH domain of Btk protein tyrosine kinase was shown to bind to PI-3,4,
and Ins- selectively (206,207).
Rameh et at. have examined the binding of several PH domains to five
different phosphoinositides (170). In these in vitro studies , radio labeled
lipids were utilized in direct binding and competitive binding experiments.
The following three PH domains were shown to selectively bind PI-3,4,
: 1.) the SOS PH domain (SOS activates Ras); 2.) the Tiam- 1 PH
domain (Tiam activates Rae); and 3.) the Grp- 1(general receptor for
phosphoinositides) PH domain (Grp- 1 may activate Art (205). The Grp-
protein was isolated based on its ability to bind to PI-3,4, in an
expression cloning assay (205). The amino-terminal PH domain of Tiam-
seems to be important for membrane localization (211-213), as mentioned
above for the PH domain of PLC8. By contrast, the PH domains of ~ARK
spectrin, OSBP (oxysterol-binding protein) were found to bind PI-3,4,
weakly and showed specificity for PI- over PI-3,4- (170). Thus
PH domains seem to have specificity for different phosphoinositides, and
published data suggest that their interaction with lipids may playa role in
recruiting proteins to the membrane.
Furthermore, data from several labs has suggested that PH domains
bind to the G~y complex. Initial experiments by Lefkowitz and colleagues
illustrated the binding of ~ARK to G~y complex (171 172). Subsequent
studies demonstrated that PH domains from ~ARK, PLCy, IRS- , Ras-
GRF, and Ras-GAP, when expressed as glutathione S-transferase fusion
proteins , can reversibly bind bovine brain G~y subunits in vitro (173).
Experiments using PH domain-containing peptides derived from ~ARK
PLCy, IRS- , Ras-GRF, and Ras-GAP were shown to behave as specific
antagonists of G~y- mediated signaling in intact COS-7 cells (174). In
addition, the PH domains of DBL, mSOS1 , IRS- , and ~ARK were shbwn
to bind G~y subunits in vitro in a dose dependent manner (174). In these
same experiments, mSOS 1 was unable to bind to G~y subunits in vitro
(174). In summary, the data generated on PH domains implies that they
playa role in the assembly of membrane-associated protein complexes that
initiate signal transduction cascades.
The last domain that I would like to discuss is shared by Drosophila /
mammalian SOS proteins and C3G. This domain is referred to as the SH3
binding domain (see Figure 3). The SH3 domain has been described in the
previous section entitled Signaling by Receptor Tyrosine Kinases. As
mentioned previously, SH3 domains bind to proline rich motifs. Upon
examination of the primary amino acid sequence of the SOS sequence, it
was discovered that the carboxy terminus of SOS is proline-rich. In 1993
two papers were published in the same issue of Nature illustrating that the
SH3 domain of GRB2 associates with the proline-rich motifs in the carboxy
terminus of SOS. Egan and coworkers were able to coimmunoprecipitate
GRB2 and SOS from Rat 1 cells (175). Furthermore , they performed in
vitro studies , using GST-Grb2myc and varous GST- mSOS1 deletion
constructs which confirmed that GRB2 was binding specifically to the C-
terminal domain of mSOS1 (amino acids 1 135- 336) (175). More
specifically, their studies indicated that GRB2 and mSOS1 association is
dependent upon the cooperative interactions of the two GRB2 SH3 domains
(175). The second paper also demonstrated the coimmunoprecipitation of
mSOS1 and GRB2 from NIH3T3 cells (176). A number of research
groups subsequently showed that Ras-GEF's are involved in signal
transduction pathways from the cell surface to Ras proteins by
demonstrating complex formation between the EGFR, GRB2 , and SOS
upon stimulation with EGF (146 177).
G. GRB2
The initial identification and characterization of SEM5 (c. elegans 
) /
GRB2 (mammalian)/ DRK (Drosophila) was a major step towards
understanding the mechanisms by which the Ras proteins are regulated in
response to extracellular mitogens. Genetic experiments in C. elegans led
to the cloning of sem5 (178). The sequence of sem5 revealed the protein
consisted of two SH3 domains and one SH2 domain. Genetic experiments
demonstrated that SEM5 serves as an adapter protein linking tyrosine
kinase receptors and Ras (179). Therefore, this discovery immediately
suggested a function for the independently cloned human homologue
GRB2. GRB2 was cloned based on the ability of its SH2 domain to bind to
tyrosine phosphorylated EGFR (180). As stated previously, a series of
papers published in 1992- 1993 demonstrated that the link between tyrosine
kinase receptors and Ras occurs via the adapter protein GRB2 (51-
146 175- 177). For instance , Buday and Downward showed that upon
stimulation with EGF, a complex of receptor, GRB2 , and mSOS 1 is
formed (176). Furthermore , there was no change in the specific activity
of mSOS 1 after stimulation of Rat 1 cells with EGF (176). This data
argued that the redistribution of mSOS 1 from the cytoplasm to the
membrane may be the major form of SOS regulation. Genetic experiments
in Drosophila showed that the adapter protein DRK is required for Ras
activation and also is able to bind to the Sevenless receptor and SOS in
vitro (181). In conclusion , the studies in Drosophila C. elegans and
mammalian cells illustrate how the signaling cascade from tyrosine kinase
receptors to Ras has been evolutionarily conserved.
CHAPTER II
INTRODUCTION
A. SOS and Cellular Signaling
Signal transmission by many receptor tyrosine kinases involves the
conversion of Ras proteins from the inactive GDP-bound form to the active
GTP-bound form (1-3). The Ras-GTP is able to associate with Raf protein
kinase and this results in the stimulation of these and multiple other protein
kinases such as MAPKs (87-88). The MAPKs catalyze the phosphorylation
of many cellular proteins , resulting in their regqlation. Therefore, the Ras
signaling cascade modulates important cellular processes such as
transcription and protein synthesis (59,88).
Stimulation with growth factors results in autophosphorylation of
tyrosine kinase receptors which results in the formation of recognition sites
for SH2 domain containing proteins. The formation of these complexes
between tyrosine phosphorylated receptor and SH2 domain containing
proteins initiates signal transduction cascades. The growth factor
stimulation of tyrosine phosphorylation of membrane receptors or receptor
substrates provides the appropriate tyrosine phosphate sites for binding the
SH2 domain of GRB2. As a result, the rapid association of GRB2 (35 180-
182) or SOS (175 180 183) proteins to complexes containing tyrosine-
phosphorylated species such as EGFR, SHC , IRS- , and SYP has been
demonstrated. For instance, competition experiments using synthetic
phosphopeptides showed that GRB2 binds directly to the EGFR via
phosphorylated tyrosines at positions 1068 and 1086 (184) and SHC binds
directly to the EGFR via phosphorylated tyrosines at positions 1173 and
992 (184). Activation of Ras proteins by receptor tyrosine kinases is
thought to result from recruitment of SOS proteins to plasma membrane
receptor substrates via adapter proteins such as GRB2. As described in
Chapter the mechanism of this recruitment involves the binding of the
SH3 domains of GRB2 with the proline-rich motifs in the carboxy terminus
of SOS proteins. For example, studies performed by Aronheim and
coworkers suggested that the GRB2 / SOS association may have two
functions. First, GRB2 may be responsible for recruiting SOS proteins to
plasma membrane sites where SOS can activate Ras. Second, GRB2
binding to the carboxy terminus of SOS may alleviate the potential
inhibition that the SOS carboxy terminus invokes on the SOS catalytic
activity. More specifically, transient transfection of NIH3T3 cells with
mSOSmutant proteins tagged with either farnesylation or myristoylation
signals resulted in localization of these SOS proteins to the plasma
membrane and as a consequence were also able to activate Ras (185).
Furthermore , SOS constructs which lacked the C-terminal GRB2 binding
domain displayed an increase in their ability to activate Ras compared to
full length SOS proteins (185). This data is consistent with their model that
recruitment of SOS to the plasma membrane via GRB2 is the primary
mechanism by which Ras is activated.
B. Sevenless Receptor Signaling
The sevenless gene of Drosophila melanogaster encodes a
transmembrane protein tyrosine kinase. The sevenless receptor functions
to ensure proper development of the Drosophila eye (90, 186). The eye
consist of - 800 repeated units called ommatidia each of which contains a
central core of eight photoreceptors surrounded by 12 accessory cells.
During development, the R 7 photoreceptor is the last of the photoreceptors
to be recruited. In the Drosophila eye binding of BOSS (Bride of
Sevenless), which is present on the neighboring R8 cells , to the sevenless
receptor tyrosine kinase (SEV) on the R7 cells leads to the downstream
activation of Ras. As a result, the R7 precursor cell is able to differentiate
to a photoreceptor neuron. Genetic experiments have led to the discovery
that dSOS and DRK (GRB2 homologue) are involved in this signaling
system and function between SEV and Ras (142 181 187Y.
In order to further understand the role of SOS in signal transduction
Karlovich and co-workers initiated an in vivo structure-function analysis of
the dSOS gene product. Deletion constructs of the dsos gene were
generated and transformed into flies in which the Sevenless signal is
attenuated in order to assess the effects of the constructs on R 
development. Their initial experiments demonstrated that in intact flies a
mutant Drosophila dSOS protein lacking the DRK/GRB2 adapter binding
COOH-terminal domain (referred to as NCat) was at least as capable as the
wildtype dSOS protein in promoting R7 cell development (188) (Figure 5).
In these experiments a genetically sensitized background (sev E4 
,. 
SOSJC2 I
SOS+ ) was used in which the Sevenless signal is attenuated, only 17% of
the ommatidia develop an R7 cell (188). In sev flies no R7 cells develop,
but in this sensitized background the SOSJC2 allele, which encodes an
overactive SOS protein , parially compensates for the loss of signal due to
the sev mutation (188). The NCatC and NCat constructs enhanced
transmission of the Sevenless signal, increasing the population of
ommatidia with R7 cells to 33% and 40% , respectively (Figure 5) (188).
In contrast, the amino-terminal domain (N), the catalytic domain (Cat), the
Figure 5. SOS constructs and their effects on Sevenless
signaling in a sensitized genetic background. (A) Predicted
protein products of the SOS constructs. (B) Effects of SOS constructs on
R7 development in a sev E4;SOS JC /Sos + genetic background. For each
genotype, one copy of a given construct was used, except for sE(PH) which
had very low amounts of expression and the results shown were obtained
from flies with two copies of the construct. The eyes were scored by the
pseudopupil technique for the presence of R7 cells. For each genotype, at
least 2000 ommatidia were counted (Taken from reference 188 , Karlovich
et al.).
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carboxy-terminal domain (C), and the Cat in combination with the C
domain (CatC) all decreased the fraction of R7-containing ommatidia
(Figure 5). In addition , the ability of the mutant dSOS protein (NCat) to
promote R 7 cell development required the expression of an intact Sevenless
protein (see Figure 6). In .these particular experiments , both NCat and
NCatC were able to promote R7 development in a sev background
(Figure 6 , A , B , and D). However, neither NCat or NCatC were able to
suppress the null allele sevd2 which makes no sevenless protein (Figure 6
, C and E). Therefore, the sevenless molecule is essential for NCat
function suggesting an interaction between NCat and Sevenless which is
independent of DRK.
In addition, these dSOS deletion constructs were tested for their ability
to act as dominant negatives using a sev lsevE4 background (188). In this
genetic background the flies have a functional Sevenless signaling system
that results in an eye containing R7 cells in all ommatidia because sev is a
recessive mutation. A construct acting as a dominant negative would be
expected to compete with endogenous components and disrupt the wild-type
signal resulting in ommatidia lacking R7 cells. The following constructs
were able to disrupt the wild-type signaling system to a modest extent:
sE(C), sE(N), sE(Cat), and sE(PH) (Table 1). Interestingly, the construct
Figure 6. Suppression of sev but not the null allele sev d2 
sE(NCat) and sE(NCatC). (A) Fraction of ommatidia in which R7
cells appear in sev E4 and sev d2 backgrounds in the presence of sE(NCatC)
and sE(NCat). For each genotype, two copies of either sE(NCatC) or
sE(NCat) were used and at least 2000 ommatidia were scored. (B
through E) Distal tangential sections from adult eyes. The dark
structures in each facet or ommatidium are light-gathering organelles
called rhabdomeres. The centrally positioned R7 rhabdomere is
marked with an arrow. (B) sev E4 ;sE(NCatC). (C) sev d2 ;sE(NCatC).
(D) sev E4 ;sE(NCat). 
eE) sev d2 ;sE(NCat) (Taken from reference 188
Karlovich et al.
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Table 1. Effects of SOS constructs on R7 development in a
sev sevE4 genetic background. In each case, at least
2000 ommatidia were scored. Two copies of each construct
were used in this assay except for sE(PH), for which expression
was low and four copies were introduced (Taken from reference188,
Karlovich et al.
lacking the NH terminal domain (CatC) had a strong dominant negative
effect , resulting in 70% of the ommatidia lacking R7 cells (see Table 
(188). In a similar manner, the CatC construct failed to rescue the S.
cerevisiae cdc25- temperature sensitive mutation (Figure 7).
Transformation of the cdc25 with the CDC25 gene, or the dSOS
complementary DNA fragments NCat or Cat resulted in rescue of the
cdc25 strain and allowing its growth at the nonpermssive temperature
(Figure 7). As a result, the ability of the Cat domain to activate Ras was
lost upon the addition of the COOH-termnus onto it which is consistent
with the hypothesis that the COOH-terminus may have an inhibitory
influence on the catalytic domain. The results from these genetic
experiments described above allow several conclusions to be made
regarding the function of SOS in the developing eye of the Drosophila.
1.) The amino-terminal region of SOS was essential for its function, 2.
The carboxyl-termnal region of SOS was not essential for its function, and
) The COOH-terminus may play an inhibitory role. Therefore, these
genetic experiments argue against a role for GRB2/DRK in the
recruitment of SOS to the plasma membrane and suggest that regions
within the NH terminal domain of SOS proteins are necessary for their
26 o 34. 5 
CDC25
.. 
NCat
Cat
CatC
pAD54
Figure 7. Complementation of a S. cerevisiae cdc2Sts
mutation by SOS constructs. Growth of the cdc25-
temperature-sensitive mutation at restrictive (34.5 OC)
and permissive (26 C) temperatures was examned after
transformation with the pAD54 plasmid containing a
complementing fragment of the S. cerevisiae CDC25
gene or the SOS cDNA fragments NCat, N, Cat, or CatC.
For each construct, two independent transformants are
shown (Taken from reference 188 , Karlovich et at.
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physiological function. It was these genetic experiments that initiated my
thesis research project.
C. esis Focus and S ecific Aims
The Focus of my Thesis is, " at is t e Mechanism b
Which SOS
Activates as in 
onse to rosine Kinase Rece tors?" The specific
aim of CHAPTER IV is to test the hypothesis proposed in the literature
which postulates that the GRB2 binding domain of SOS is necessary for
SOS to be recruited to the plasma membrane where it can activate Ras. 
;ziY
order to test the proposed hypothesis thee specific questions were
;;.
addressed: 1.) What are the roles of the NHz terrhnal and COOH-
terminal
regions of dSOS?, 2.) Is GRB2 able to bind regions in the dSOS protein
that reside in the NHz terminal or catalytic domains?, and 3.
) Are there
other important structural elements within the NHz terminal domain of
dSOS that are required for its ability to activate Ras? The specific aim of
CHAPTER VI is to test the hypothesis that the amino-terminal domain of
dSOS, specifically the PH and DBL regions, is important for its membrane
association. In order to test the proposed hypothesis two specific questions
were addressed: 1.) What is the distribution of various dSOS mutant
proteins in 293 cells? and 2.) Can neomycin which binds PI-
:",
strongly, inhibit the ability of various dSOS mutant proteins to associate
with total membranes in 293 cells?
CHAPTER III
MA TERIALS AND METHODS
A. Construction of pCMV5-dSOSHA deletion constructs
The dSOS constructs were engineered using standard molecular biology
techniques. Each construct was modified at its respective COOH-terminus
to encode a hemagglutinin (HA) epitope extension. The 9-amino acid
peptide sequence Tyr - Pro- Tyr - Asp- V al- Pro- Asp- Tyr - Ala of the influenza
HA which is specifically recognized by the monoclonal antibody 12CA5
(189), was added to the 3' end of the dSOS construct coding sequences.
The dSOS cDNA constructs encode the following amino acids: NCatCHA
1596; NCatHA, 1- 1125; NCat8PHHA, 1-475 and 592-1125; PHCatHA
433- 1125; CatHA, 758- 1125; CatCHA, 1-53 and 681- 1596; CHA, 1-
681-690 , and 1040- 1596; NHA, 1-690; NCat8200HA, 1-311 and 681-
1125; NCat8300HA, 1-219 and 681-1125; DBLIIIPHCatHA 311- 1125;
and PHCatHA(w-- g, the conserved tryptophan in the PH domain was
mutated to a glycine) (see Figures 9 and 22).
:j,
B. Cell lines and transient transfections
COS- 1 cells (American Type Culture Collection RL 1650) were grown
in DMEM medium containing 10% bovine calf serum, and 293 cells
(American Type Culture Collection CRL 1573) were grown in DMEM
medium containing 10% calf serum. These cells were maintained in a 37
c incubator at 5% CO ' Plates of COS- 1 cells and 293 cells were
transfected using the CaP0 method according to standard protocols.
C. Immunoprecipitation
Cells (100 mm plates) were washed and lysed in 1.0 ml of an ice-cold
buffer composed of 0. 05 M NHiS04
)' 
20 mM Hepes (pH 7.4), 10 %
glycerol , 1.0 % Triton X- 100, 0. 1 % Tween 20, 1 mM EDTA, 1.0 mM
DTT, 1 mM benzamidine, 1 mM phenylmethylsulfonyl chloride , and
aprotinin, pepstatin, and leupeptin at 10 jlg/ml each. Lysates were
clarified by centrifugation at 13 000 x g for 10 min. at 4 C. Lysates were
next incubated with the desired antibody (anti-HA polyc1onal) and protein
Sepharose (Pharmacia) for approximately 16 hours at 4
Immunoprecipitates were washed five times in a buffer containing 0.05 M
NHiS0
)' 
20 mM Hepes (pH 7.4), 10 % glycerol, 1.0 % Triton X- 100, 0.
% Tween 20 , and 0. 1 mM EDT A and then boiled in reducing SDS gel
sample buffer for 5 min. Samples were resolved by SDS-PAGE and
transferred to nitrocellulose membrane (190) using an electroblotting tank
at 110 mA overnight.
D. Immunoblotting
Blots were blocked for a minimum of 30 minutes in 3% nonfat dry
milk, 2.9% NaCl, 0.5% BSA, 100 mM Tris-HCl (pH 7.4), 1 % Tween-20.
Blots were next incubated at room temperature with gentle agitation for a
minimum of 2 hours in primary antibody, which was diluted in a tris
buffered saline solution (TBS) with 0. 1 % Tween-20. Subsequently, the
blots were washed three times in TBS /0. 1 % Tween-20 buffer (first wash
for 15 min and last two washes for 5 min each). The blots were then
incubated for 25 min with the appropriate horseradish peroxidase
conjugated secondary antibody at a 1 : 5 000 dilution in TBS / 0. 1 %
Tween-20 solution. Blots were again washed in the same manner as
described above. Primary antibodies were detected by enhanced
chemiluminescence (Amersham or NEN) and densitometry was performed
using a Pharmacia LKB 2222-020 ultrascan XL.
E. Immunofluorescence
COS- 1 / 293 cells were plated on glass coverslips and transiently
transfected with the desired DNA construct via CaP0 mediated method.
Approximately 48 hours after transfection, the cells on the coverslips were
washed three times in ice-cold phosphate-buffered saline (PBS) consisting
of 10. 1 mM NazHP0 , 1.8 mM KH , 3.35 mM KCl, 170 mM NaCl
68 mM CaCl , and 0.49 mM MgCl . Cells were next fixed in 4 %
formaldehyde in PBS for 10 min at room temperature. Subsequently, the
cells were washed three times with ice-cold PBS and permeabilized with
5 % Triton X- 100 and 1.0 % FBS in PBS for 15 min at room
temperature. After two washings in the permeabilization buffer, cells were
incubated for two hours with primary antibody (anti-HA at a dilution of
1: 1 000 in permeabilization buffer) at room temperature with gentle
shakng. The cells were next washed four times with ice-cold
permeabilization buffer for 5 min each time with shaking and then
incubated for 30 min with fluorescein isothiocyanate-conjugated anti-mouse
(TAGO)(dilution of 1:1 000 in permeabilization buffer) with agitation.
After incubation with the secondary antibodies , the cells were thoroughly
washed, first with ice-cold permeabilization buffer (4 times) and once with
PBS. Last, the coverslips were mounted on slides using 90 % glycerol
plus 2.5% DABCO (1,4 diazabicyclo-(2 2)-octane). Immunofluorescence
was visualized by digital imaging microscopy.
F. Cell labeling and Ras -activation assay
Two days after transfection, the cells (60 mm plates) were washed twice
with phosphate-free DMEM (Gibco) supplemented with 25 mM Hepes and
2 mM pyruvate. Subsequently the cells were labeled with carer-free
PJorthophosphate (1.0 mCi / ml) (NEN) for 4 hours at 37 oC in 1.5 ml
of phosphate-free DMEM supplemented with 25 mM Hepes and 2 mM
pyruvate. Each plate of cells was next lysed in 0.9 ml of buffer composed
of 50 mM Hepes, 1 % Triton X- 100, 100 mM NaCl, 5 mM MgCl , 1 mg/
ml BSA, 1 mM PMSF, 10 /lg/ml aprotinin, 10 /lg/mlleupeptin, and 1 : 10
dilution of 1742 supernatant (anti-Ras antibody). Lysates were clarified by
centrifugation at 13,000 x g for 5 minutes at 4 oC. Supernatants were
transferred to a new tube and combined with 0.2 ml of a detergent solution
(0.5 M NaCl, 0.5% DOC, and 0.05% SDS) and 30 ul of goat-anti rat
Sepharose (Sigma). After overnight incubation at 4 C on an end-over-end
mixer, immune-complexes were pelleted by centrifugation at 13 000 x g
for 40 seconds. The goat-anti rat Sepharose complexed with anti-Ras
antibody was next washed 8 times in a wash buffer composed of 50 mM
Hepes , 0.5 M NaCl, 5 mM MgCl , 0. 1 % Triton X- 100 , and 0.005% SDS.
Guanine nucleotides bound to Ras were eluted by the addition of 20 l of
elution buffer ( 0.075 M KHzP04 pH 3.4, 5 mM EDTA, 0.5 mM GTP, and
5 mM GDP) to each sample and heating the samples for 3 min at 85
The samples were clarified by centrifugation, and 8 
l of each sample was
spotted onto a sheet of polyethyleneimine cellulose (VWR). PJGTP and
PJGDP were separated by developing the chromatograms with 0.65 M
P04 (pH 3.4) (191). GTP and GDP standards were visualized with
short wave UV. The radiolabeled nucleotides were visualized by
autoradiography. The GTP and GDP spots on the' TLC plate were excised
and the amount of eZPJorthophosphate incorporated was determined using a
counter (Beckman LS 5000 TD).
G. In vitro binding assay
Spodoptera frugiperda Sf9 cells were cultured in Grace s complete
medium and infection with high titer baculovirus stocks of either NCatCHA
or NCatHA was carried out according to standard protocols. NCatCHA
and NCatHA cDNA constructs were subc10ned into the baculovirus transfer
vector pVL1393 for expression in Sf9 cells. Frozen pellets of baculovirus-
infected Sf9 cells (NCatCHA, NCatHA, and wild-type) were homogenized
on ice using a 2-ml homogenizer (10 strokes) in 1 ml of told lysis buffer
(phosphate-buffered saline with 10 mM NaF, 1 mM dithiothretitol (DTT),
1 mM vanadate, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride
and aprotinin , pepstatin, and leupeptin at 10 g/ml each). Homogenates
were spun in a micro centrifuge at 15 000 x g for 15 min at 4 oC. The
supernatants were removed and assayed for total protein content using the
Bradford method (192). Proteins from each lysate were dissolved in
sample buffer, subjected to SDS-P AGE, and stained with Coomassie
Brilliant Blue.
Equal amounts of protein from each lysate were incubated with 30 ul of
glutathione-Sepharose (Pharmacia), which was prebound with GST or
GST-GRB2 , on an end-over-end mixer at 4 C for 2 hours. GST and GST-
GRB2 fusion plasmid were gifts from Dr. J. Schlessinger (New York
University, New York, NY). The Sepharose was pelleted by centrifugation
at 15 000 x g for 2 min at 4 C. Pellets were washed twice with 20 
Hepes , pH 7. , 10% glycerol, 100 mM NaCl, and 1 mM DTT , twice with
20 mM Hepes , pH 7. 10% glycerol, 500 mM NaCl , and 1 mM DTT and
once with 20 mM Hepes , pH 7. , 10% glycerol, 100 mM NaCl , and 1 mM
DTT. Proteins remaining bound to the GST or GST-GRB2 were dissolved
: '
in SDS-PAGE sample buffer. Samples were loaded on SDS-
PAGE gels
(6%) and transferred to nitrocellulose filters. Filters were probed with
anti-HA monoclonal antibody, and antibody bound proteins were visualized
using ECL (Amershem Corp.) according to the manufacturer
specificatio
H. Parial purificatio of Ras
Sf9 insect cells were cultured in Grace s complete medium and infected
with a high titer baculovirus stock of Ras (gift from Dr. Martin McMahon,
DNAX, Palo Alto, CA). Frozen pellets (-1.0 ml) of baculovirus-
infected
Sf9 cells were homogenized on ice using a Dounce homogenizer (20
strokes) in 10.0 ml of cold lysis buffer composed of 50 mM Tris-
HCl, pH
150 mM NaCl, 5 mM MgCl , 200 11M GDP, 1 11M DTT, and 10 Ilg/ml
each of leupeptin and aprotinin. After homogenization, Triton X -
114 was
added to achieve a final concentration of 1.0% and the lysate was
centrifuged at 100,000 x g at 4 C for 30 min. The supernatant was
removed and separated into aqueous and detergent phases by 
warmng to
C for 2 min and subsequent centrifugation at 400 x g for 2 min. Two
sequential phase-separations were performed to wash 
the original
detergent phase. The aqueous and detergent phases were next separated
and adjusted to 1.0% Triton X-114. The detergent phase was dialyzed
against a buffer composed of 20 mM Tris-HCl, pH 7. 5, 0.05% DOC, 50
mM NaCl, 1 mM DTT, and 5 mM MgCl and then centrifuged at 10,000 x
gat 4 C for 10 min. Post-translationally processed Ras proteins were
purified by anion exchange chromatography from the original detergent
phase on a Cellex D column (- 5 ml). The column was equilibrated and
washed with a buffer composed of 50 mM Tris-HCl pH 7. 5 % DOC,
20 mM N aCl, and 1 mM DTT. Processed Ras proteins were eluted in three
1.5 ml fractions of buffer containing 50 mM Tris-HCl pH 7.
DOC , 500 mM NaCl, and 1 mM DTT. Ras proteins were dialyzed against
a buffer composed of 20 mM Tris-HCl, pH 7. 5% DOC, 50 roM NaCI,
1 mM DTT , and 5 mM MgC1 and stored at - C until use.
I. In vitro Ras activation assay
The partially purified Ras proteins were first tested for their ability to
bind eH)GDP. Ras proteins were incubated with 1.0 I-M (3HJGDP in a
buffer composed of 25 mM Tris-HCl, pH 7. 100 mM NaCl, 0.4 mg/ml
BSA, 1.0 mM DTT, and 1.0 mM EDTA for 30 min at 30 C. The exchange
was stopped by adding 1.0 ml of ice cold buffer composed of 25 mM Tris-
HCI, pH 7. 100 mM NaCl, 10.7 mM MgCl , 1.0 mM DTT , and 0.4
mg/ml BSA and incubation on ice for 5 min. The radioactivity bound to
Ras was determined by immunoprecipitating Ras with the Ras antibody
(1:10 dilution of 1742 cell supernatant) and 80 ul of Goat-anti Rat
Sepharose (Sigma) in the presence of 0.5% DOC and 0.05% SDS. After
incubation for 1 hour at 4 C on an end-over-end mixer, the goat-anti rat
Sepharose complexed with anti-Ras antibody was next washed 3 times in a
wash buffer composed of 50 mM Hepes , 0.5 M NaCl, 5 mM MgCl , 0. 1 %
Triton X- 100, and 0.005% SDS. The beads were drained well and
resuspended in 1.0 ml of opti-fluor and the radioactivity associated with the
beads was determined using a 
counter (Beckman LS 5000 TD).
After demonstrating that the partially purified Ras was active , the Ras
was utilized in experiments to test the ability of NCatCHA and NCatHA to
catalyze the exchange of GDP for GTP on the Ras in vitro. First, frozen
pellets of baculovirus- infected Sf9 cells (NCatCHA and NCatHA) were
homogenized on ice using a 2- ml homogenizer (10 strokes) in 1 ml of cold
lysis buffer (phosphate-buffered saline with 10 mM NaF , 1 mM
dithiothretitol (DTT), 1 mM vanadate , 1 mM benzamidine , 1 mM
phenylmethylsulfonyl fluoride, and aprotinin, pepstatin, and leupeptin at 10
Ilg/ml each). Homogenates were spun in a microcentrifuge at 13,000 x g
for 15 min at 4 C. The supernatants were removed and assayed for total
protein content using the Bradford method (192). Lysates (- 5 mg) were
next incubated with the desired antibody (anti-HA polyclonal) and Protein
Sepharose (Pharacia) for approximately 16 hours at 4
Immunoprecipitations were washed five times in a buffer containing 0.
NHiS
)' 
20 mM Hepes (pH 7.4), 10% glycerol, 1.0% Triton X- 100,
1 % Tween 20, and 0. 1 mM EDTA and the beads were drained well. 
Ras
was next equilibrated at room temperature for 10 min in a buffer
composed of 20 mM Tris-HCl, pH 7. 50 mM NaCl, 5 mM MgCl
, 1.0
mg/ml BSA, 1.0 mM DTT, and 0.05% sodium cholate. The binding assay
was initiated by aliquoting 25 J.l of the Ras mixture into tubes containing
25 J.l of 20 mM Tris-HCl, pH 7. 50 mM NaCl , 5' mM MgCl , 1.0 mg/ml
BSA, 1.0 mM DTT, 0.05% sodium cholate, 1.0 J.M eH)GTP (31.5
Ci/mmole) , and the immunoprecipitated NCatCHA or NCatHA (drained
beads). The final concentration of Ras in each reaction was - 100 nM.
The binding reactions were carried out for the indicated times ( 10, 30, or
60 min) at 25 C and subsequently stopped by the addition of 1.0 ml ice-
cold stop buffer composed of 20 mM Tris-HCl , pH 7. 50 mM NaCl
, and
5 mM MgCl . The radioactivity bound to Ras was determined by
immunoprecipitating Ras with the Ras antibody (1: 10 dilution of 1742 cell
supernatant) and 60 ul of goat-anti rat Sepharose (Sigma) in the presence of
'1'1
5% DOC and 0.05% SDS. After incubation for 1 hour at 4
C on an end-
over-end mixer, the goat-anti rat Sepharose 
complexed with anti-Ras
antibody was next washed 3 times in a wash buffer composed of 50 mM
Hepes , 0.5 M NaCl, 5 mM MgCl , 0. 1 % 
Triton X- 100, and 0.005% SDS.
The beads were drained well and resuspended in 1.0 ml of opti-
fluor and
the radioactivity associated with the beads was determined using a 
counter (Beckman LS 5000 TD).
J. Membrane fractionation experiments
293 cells (lOO-mm plates) were harvested approximately 60 hours after
transfection and washed once with cold PBS. Cells were 
homogenized for
20 strokes with a motor-driven Teflon-
glass homogenizer in 1.5 ml (for
two 100 mm plates) of ice-cold buffer containing 20 mM Tris-
HCl, pH 7.
1 mM EDT A, 255 mM sucrose, 1 mM DTT, 1 mM benzamidine
, 1 mM
phenylmethylsulfonyl fluoride , and aprotinin and leupeptin at 10 
I-g/ml
each). Homogenates were spun in a microcentrifuge at 800 x g for 5 min
at 4 C to remove nuclei and unbroken cells. Next
, the homogenate was
spun at 100,000 x g for 25 min at 4 C. The 
resulting supernatant was
saved as cytosol and the pellet was washed twice with a buffer composed of
IIW
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05 M NH (S04)' 20 mM Hepes (pH 7.4), 10% glycerol, 1.0% Triton 
100, 1 % Tween 20, 1 mM EDT A, 1.0 mM DTT, 
1 niM benzamidine, 
mM phenylmethylsulfonyl fluoride, and aprotinin, pepstati
, and leupeptin
at 10 g/ml each. The total membrane pellet was then resuspended in 1.
ml of this same buffer. Total membranes were clarified by spinning at
13,000 x g for 10 min at 4 C which resulted in a Triton X-
100 insoluble
fraction (pellet). Protein in the cytosol 
and membrane fractions was
quantitated using the BCA protein determnation kit with BSA as the
standard. HA-tagged proteins were immunoprecipitated from cytosol and
membrane fractions as described previously, using anywhere from 1.
0 mg
to 3.0 mg of total protein.
K. Neomycin inhibition experiments
Cells were fractionated as previously described. After the 100,
000 x g
spin, the tota membraes were resuspended in a buffer composed of 
mM Tris-HCl, pH 7. 1 mM EDTA, 255 mM sucrose
, 1 ro DTT, 1 mM
benzamidine, 1 mM phenylmethylsulfonyl fluoride, and aprotini
and
leupeptin at 10 
g/ml each). Resuspended membranes were incubated for
10 min at 4 C in the presence or absence of neomycin (15 or 40 
M).
Total membranes were pelleted by spinning again at 100,
000 x g for 24
. TWrr!!
min at 4 C. Supernatants were saved and used for anti-
immunoprecipitations. The particulate fraction was then resuspended in 1.
ml of a buffer composed of 0. 05 M NHiS04
)' 
20 mM Hepes (pH 7.4),
10% glycerol, 1.0% Triton X- 100, 0. 1 % Tween 20, 0. 1 mM EDTA, 1.0
mM DTT, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride , and
aprotinin, pepstatin, and leupeptin at 10 J.g/ml each. The particulate
fraction was clarfied by spinning at 13 000 x g for 10 min at 4 C which
resulted in a Triton X- 100 insoluble fraction (pellet). Protein in the
cytosol and membrane (particulate) fractions was quantitated using the
BCA protein determination kit with BSA as the standard. HA-tagged
proteins were immunoprecipitated from cytosol and membrane fractions as
described previously, using anywhere from 1.0 mg to 3.0 mg of total
protein.
CHAPTER IV
CHARACTERIZATION OF FUNCTIONAL DOMAINS OF 
SOS
A. Specific Aims and Rationale
Ras proteins are activated primarily by specific guanine nucleotide
exchange factors such as the Son of Sevenless (SOS) proteins. 
Activation
of Ras is postulated to occur in response to plasma membrane localization
of a complex containing SOS and the adapter protein GRB2. 
The specific
aim of this Chapter is to test the hypothesis proposed in the literature which
postulates that the GRB2 binding domain of SOS is 
necessar for SOS to be
recruited to the plasma membrane where it can activate Ras (Figure 8).
The rationale that this model proposed in the literature may not be
correct is based on preliminary data from Chris Karlovich and colleagues
at UCLA. These genetic experiments are discussed thoroughly in Chapter
II. Briefly, Karlovich et at. applied an in vivo structure-
function analysis
of the dSOS gene product in order to map important functional domains of
the protein. These experiments in intact flies suggested that there are other
important functional domains in the NHz terminus of dSOS and that the
DRK (GRB2) binding domain was not required for dSOS function.
Therefore , data generated using the Drosophila 
system suggest that the
Figure 8. Model for the activation of Ras by SOS in response to
growth factors (Based on reference 185). SOS C-terminal sequences
were shown to bind to the SH3 domains of GRB2. Therefore, it was
postulated that GRB2 serves to recruit the cytosolic SOS protein to the
plasma membrane. This model proposes that GRB2 binds to activated
growth factor receptors via the SH2 domain of GRB2. GRB2 binding to
the receptors results in recruitment of SOS protein from the cytosol to the
plasma membrane where SOS is able to active Ras.
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model proposed for the mammalian system (Fig. 8) involving SOS
recruitment via GRB2 binding requires critical examination.
B. Construction of Drosophila SOS mutant proteins
Drosophila SOS cDNA constructs were engineered in order to evaluate
the functions of its three major domains: 1.) catalytic domain, 2. ) COOH-
termnal domain, and 3.) the NH termnal domain. The catalytic domain
Cat, was originally defined as the region which shares homology with the
Saccharomyces cerevisiae Ras activator protein CDC25 (123). The
domain COOH-terminal to Cat is denoted as C and consists of the
characteristic proline-rich motifs which have been demonstrated to bind to
the SH3 domains of GRB2 (51- 146 175- 177). The region NH terminal
to Cat is denoted as N. Hemagglutinin epitope (HA)-tagged constructs
corresponding to those represented in Figure 9 were prepared and ligated
into the mammalian expression vector pCMV 
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NCatCHA N
1 53
Catalytic Proline-Rich
f::Jii681 1125 1596
CHA
CatCHA N
NCatHA N
NHA
CatHA
HAEPITOPE: YPYDVPDY A
Figure 9. Schematic representation of the HA-tagged native
and mutant SOS constructs employed in the experiment of
Fig. 12. The amino acid numbers are denoted beneath NCatCHA.
C. Stimulation of Ras activation by expression of recombinant dSOS
proteins
COS- 1 cells were transiently cotransfected with the constructs listed in
Figure 9 and the Ras cDNA which was also sub cloned into pCMV5. Next
the cells were labeled for four hours with (32p)orthophosphate in serum /
phosphate-free media. The cells were lysed and the Ras was
immunoprecipitated using an anti-Ras monoclonal antibody.
Immunofluorescence studies illustrated that the Ras was expressed virtally
exclusively at the cell surface and also Ras was expressed at relatively the
same level in each condition as verified by immunoblotting (Figure 10).
Furthermore, the HA-tagged constructs could be readily visualized by
western blotting (see Figure 11) or immunofluorescence (data not shown)
when transiently expressed in either COS- 1 or 293 cells.
Several studies have been published which demonstrate that the
catalytic domain of SOS alone, as expected, possesses intrinsic guanine
nucleotide exchange activity. Banerjee and coworkers showed that the
catalytic domain of dSOS (CatHA construct) is able to rescue S. cerevisiae
with the CDC25 mutation which is responsible for inactivating endogenous
Ras exchange activity (Figure 7) (188). In addition, the catalytic domain of
human SOS generated in Sf9 cells was fully effective in catalyzing the
Figure 10. Immunoprecipitation of transiently expressed Ras.
Western Blot of anti-Ras immunoprecipitates with the anti-Ras antibody.
COS- 1 cells were transiently co-transfected with the Ras (2 g) and the
HA-tagged dSOS cDNAs (5 g each) shown. (32PJOrthophosphate-labeled
cells were then lysed, and the cleared lysate was immunoprecipitated with
anti - Ras antibody as described in Materials And Methods section. Immune-
complexes were separated by SDS-PAGE (12.5% acrylamide) and
immunoblotted with the anti-Ras antibody. Protein bands were visualized
by enhanced chemiluminescence (NEN).
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Figure 11. Immunoprecipitation of transiently expressed HA-
tagged dSOS constructs. COS- 1 cells were transiently transfected with
NCatCHA, NCatHA, CHA, CatHA, and CatCHA. Forty eight hours after
transfection cells were lysed in lysis buffer containing 1 % Triton/O. 1 %
Tween. Cleared lysates (500 g protein) were incubated overnight
with 20 l of Protein-A Sepharose and 15 l of anti-HA monoclonal
antibody. Immunoprecipitates were washed five times in 1 % Triton/O. 1 %
Tween. Immune complexes were separated by SDS-P AGE and
immunoblotted with the anti-HA antibody. Protein bands were visualized
by enhanced chemiluminescence (NEN).
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exchange of GDP for GTP on Sf9 cell-purified K-Ras in vitro (193).
Interestingly, CatHA had no substantial stimulatory effect of (3ZpJ GTP
binding to Ras when expressed in either intact COS- 1 (Fig. 12, lane 5) or
293 cells (Fig. 22, lane 7). Therefore , although the catalytic domain of
dSOS possesses intrinsic guanine nucleotide exchange activity, the data in
Figures 12 and 22 clearly indicate that the catalytic domain alone is unable
to catalyze the exchange of GDP for GTP on Ras when overexpressed
along with Ras in mammalian cells.
The failure of CatHA to activate Ras in intact cells suggested that the
GRB2 binding domain of SOS is required to car out this function.
Several studies published in the literature argue that GRB2 plays a role in
recruiting SOS to the plasma membrane where it can activate Ras.
However, the evidence for this is very limited and indirect. Unexpectedly,
the CatCHA construct which contains both the catalytic and COOH-termnal
domains of dSOS failed to cause Ras activation when co-expressed with Ras
in the COS cell system (Fig. 12 , lane 6). Surprisingly, transfection of the
NCatHA cDNA construct which encodes for the complete NH termnal and
catalytic domains of dSOS resulted in an increase in the amount of
PJGTP bound to Ras (Fig. 12 , lane 4). NCatHA seems to be even more
active than NCatCHA (Fig. 12 , lanes 2 and 4). However this is probably
on the graph represents cells that were transfected with Ras only.
Figure 12. Stimulation of Ras GTP/GDP exchange in intact
cells by expression of recombinant dSOS constructs
NCatCHA or NCatHA. (A) COS- 1 cells were transiently co-
transfected with the RAS (2 g) and the HA-tagged dSOS cDNAs (5 
each) shown. eZPJOrthophosphate-labeled cells were then lysed, and the
cleared lysate was immunoprecipitated with anti-Ras antibody as described
in Materials And Methods section. The positions of the GTP and GDP
standards are indicated. Lanel represents cells that were transfected with
Ras only; lane , with NCatCHA only. (B) Graphic
representation of Ras activation by expression of NCatCHA or NCatHA in
COS- 1 cells. The GTP and GDP spots on the TLC plate were excised, and
the amount of ( PJorthophosphate incorporated was determned using a ~
counter. The ratio of GTP to GDP was calculated and expressed as a
percentage, and the values shown represent the average of three individual
experiments with vertical bars denoting standarderrors. The leftmost bar
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not the case because Western blotting and immunofluorescence studies
using the anti-HA antibody indicated that NCatHA may be expressed to a
greater extent then NCatCHA. Furthermore, as expected, transfection of
either the NHA or CHA constrcts in COS- 1 cells had no effect on
pJGTP binding to Ras (Fig. 12 , lanes 3 and 7). If the Ras cDNA was
omitted from the transfection, then no C PJGTP- Ras could be detected (Fig.
, lane 8). The results described above for COS- 1 cells were also obtained
using 293 cells although the magnitude of Ras activation by NCatHA was
greater than in COS- 1 cells due to the high levels of protein expression
achieved in the 293 cells (Figure 22 , lane 2).
D. NCatHA is unable to associate with GRB2 in vivo and in vitro
One trivial explanation to account for the data in Fig. 12 is that GRB2
is also able to bind to regions in the dSOS protein that are upstream of the
catalytic domain. The ability of GRB2 to associate with dSOS constructs
containing the C-terminus was first tested by using lysates of COS- 1 cells
which had been transiently transfected with the desired cDNA constructs.
COS- 1 cells were transiently transfected with either NCatCHA, CHA, or
CatCHA, and GRB2 protein was immunoprecipitated using anti-GRB2
antibody. All of the HA-tagged dSOS proteins were expressed efficiently
as detected by immunoblotting with the antibody raised against the C-
termnus of dSOS (Fig. 13). This antibody is referred to .as the anti-dSOS
COOH antibody. Immunoprecipitation of the lysates with anti-GRB2
antibody and subsequent western blotting with the anti-COOH antibody
revealed that NCatCHA, CHA, and CatCHA were able to associate with
GRB2 in COS- 1 cells. In a similar manner, 293 cells were transiently
cotransfected with either NCatCHA or NCatHA in order to determine if
GRB2 could associate with NCatHA present in either the cytosolic or total
membrane fractions. Immunoprecipitation of the cytosol (S) and total
membrane fractions (P) with anti-HA (Fig. 14) and subsequent
immunoblotting with the anti-GRB2 antibody strated that GRB2 is
unable to associate with NCatHA in vivo. However, GRB2 is able to
associate with NCatCHA presumably via the COOH-terminus (Fig. 14).
In addition, the ability of NCatHA to associate with GRB2 was
examined in vitro. HA-tagged NCatC and HA-tagged NCat dSOS proteins
were expressed in the baculovirus-insect cell system (Fig. 15) and assayed
for their ability to associate with GRB2 using a GST-GRB2 fusion protein.
Based on coomassie staining, the concentration of NCatHA protein is
estimated to be - 15-20 mg/L and the concentration of NCatCHA protein is
estimated to be - 5 mg/L. As ilustrated in Fig. 16 (lanes 2 and 3) lysates
- -- - _ - - - --- - - - -
Figure 13. Association of GRB2 with NCatCHA, CatCHA, and
CHA in COS-l cells. Western Blot of NCatCHA, CatCHA, and CHA
from anti-HA immunoprecipitation and anti-GRB2 immunoprecipitation.
COS- l cells were transiently transfected with NCatCHA, CatCHA, CHA, or
vector alone. Forty eight hours after transfection cells were lysed in a 1 %
Triton/O. 1 % Tween buffer. For anti-HA immunoprecipitations , cleared
lysate (1.0 mg) was incubated overnight with 30 Jll of Protein-A Sepharose
and 20 Jll of the anti-HA antibody. For GRB2 immunoprecipitations
cleared lysate (1.0 mg) was incubated overnight with 30 Jll GAM
Sepharose and 4 ul of the anti-GRB2 antibody (UBI). Immunoprecipitates
separated by SDS-PAGE (6% acrylamide) and immunoblotted with anti-
dSOS-COOH antibody. Protein bands were visualized by enhanced
chemiluminescence. This experiment was repeated a total of two times.
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Figure 14. Association of NCatCHA but not NCatHA with
GRB2 in 293 cells. (A) Anti-HA western blot of NCatHA and
NCatCHA immunoprecipitates from cytosol (S) and total membrane
fractions (P). (B) Anti-GRB2 western blot of NCatHA and NCatCHA
immunoprecipitates from cytosol (S) and total membrane fractions (P).
293 cells were transiently transfected with NCatHA (10 j.g) or NCatCHA
(10 j.g) via the CaP0 mediated method. Approximately 60 hours later
separated by SDS-PAGE (6% acrylamide, anti-HA and 12% acrylamide
the cells were homogenized in the presence of Tris/EDTA/sucrose and
protease inhibitors. The homogenate was precleared and the resulting
homogenate was centrifuged at 100 000 x g for 25 min at 4 C. The
resulting supernatant represents the cytosol, and the pellet represents the
total membrane fraction. Total protein in the cytosol and membrane
fractions was determined, and HA-tagged dSOS proteins were
immunoprecipitated from both fractions. Immunoprecipitates were
anti-GRB2 blot) and blotted using a 1/1000 dilution of the monoclonal anti-
Cruz). Protein bands were visualized by enhanced chemiluminescence.
HA antibody or a 1/5000 dilution of monoclonal GRB2 antibody (Santa
The experiment was repeated a total of two times.
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Figure 15. Expression of HA-tagged NCatC and NCat dSOS
proteins in the baculovirus insect cell system. Sf9 cells . were
infected with a high titer baculovirus stock of NCatCHA and NCatHA.
Cells were homogenized and total protein content of the lysates was assayed
using the BCA kit (BioRad). Total protein was solubilized in sample
buffer and resolved by SDS-P AGE on 6% acrylamide gels. After
resolution, proteins were detected by Coomassie staining. The lanes are
designated as follows: Lane1 , molecular weight markers; Lane 2 , lysate
(40 g) from wildtype infected cells; Lanes 3, , and 13 , lysate (5
, 20, 60 , 100 , and 200 g, respectively) from NCatCHA infected cells.
Lanes 4 , 6, 8, 10, 12 , and 14 , lysate (5 , 10 , 60 100, and 200 
respectively) from NCatHA infected cells. The positions of NCatCHA and
NCatHA are indicated.
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Figure 16. Association of recombinant NCatCHA but not
NCatHA protein with GST- GRB2 fusion protein. Lanes 1-
represent equal amounts of protein from total lysate of Sf9 cells infected
with wild-type , NCatHA, and NCatCHA baculoviral stocks , respectively.
The positions of NCatHA and NCatCHA are indicated. In lanes 9, equal
amounts of sample were loaded, and proteins associating with GST or
GST-GRB2 were detected by immunoblotting with anti-HA. The sample
loaded in lane represents GST -GRB2 incubated with phosphate-buffered
saline alone. The sample loaded in lane represents GST -GRB2 incubated
with lysates from wild-type infected cells. Proteins remaining bound to
the GST or GST -GRB2 were dissolved in SDS-P AGE sample buffer.
Samples were loaded on SDS-PAGE gels (6%), and transferred to
nitrocellulose filters. Filters were probed with anti-HA monoclonal
antibody, and antibody-bound proteins were visualized by using enhanced
chemiluminescence. This experiment was repeated for a total of two times.
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of Sf9 cells expressing NCatHA or NCatCHA displayed immunoreactive
bands at the expected mobilities, 125 and 180 kDa respectively, when
electrophoresed on SDS-P AGE and subsequently immunoblotted with anti-
HA monoclonal antibody. As a negative control, the wild-type Sf9 cell
lysates were used and failed to display any immunoreactivity under similar
conditions (Fig. 16, lane 1). Incubation of Sf9 celllysates containing
NCatCHA protein with a GST-GRB2 fusion protein but not GST alone
resulted in the adsorption of the full-length dSOS protein (Fig. 16, lanes 6
and 7). However, under similar conditions the baculoviral-expressed
NCatHA protein failed to associate with the GST-GRB2 fusion protein
(Fig. 16 , lane 9). This in vitro binding data indicate that the ability of
NCatHA to cause Ras activation when expressed in COS- 1 /293 cells is
independent of high affinity GRB2 binding.
E. Purification and in vitro activation of Ras by NCatCHA and NCatHA
One possibility for these in vitro binding results could be that the
NCatHA protein was not folding properly when expressed in Sf9 cells and
therefore not functionaL In order to explore this possibility, the ability of
NCatHA and NCatCHA to activate Ras in vitro was tested. Sf9 cells
expressing Ras proteins were harvested four days after infection with a
was solubilized in sample buffer and analyzed by immunoblot analysis as
Figure 17. Expression of Ras in the baculovirus insect cell
system. Sf9 cells were infected with a high titer baculovirus stock of Ras.
(A) Time course of Ras expression. An aliquot of the infected cells was
taken on the indicated days after infection. Cells were homogenized and
total protein content was assayed using the BCA kit (BioRad). Total protein
(25 g) was solubilized in sample buffer and resolved by SDS-PAGE on
12.5% acrylamide gels. After resolution, proteins were transferred
electrophoretically and immunoblotted using an anti-Ras antibody (1742
cell supernatant). Antibody bound proteins were visualized by enhanced
chemiluminescence. (B) Separation of post-translationally processed Ras
proteins from unprocessed Ras proteins. Cells were homogenized four
days after infection. After homogenization, Triton X- 114 was added to a
final concentration of 1.0% ,and the lysate was centrifuged. The pellet was
solubilized in sample buffer. The supernatant was removed and separated
into aqueous and detergent phases. Total protein (25 g) from both phases
described above. Supernatant represents the aqueous phase.
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Figure 18. Partial purification of processed Ras proteins. Post-
translationally processed Ras proteins were purified by anion exchange
chromatography from the original detergent phase (see Fig. 17) on 
Mono Q column via FPLC (Flow Rate = 0.6 ml/min). Bound proteins
were eluted (0.5 ml) using a linear NaCl gradient (0-500 mM). Protein
concentration in the collected fractions was determned using BCA assay
(BioRad). Fractions were subsequently analyzed by SDS-PAGE (12.5%).
(A) Western blot analysis of the collected fractions using the anti-Ras
(1742 supernatant) antibody. (B) Coomassie stain of the collected fraction.
The lanes in each case are identical except the coomassie stained gel shows
the molecular weight markers to the left of Lane 1. The Lanes are
designated as follows: Lane 1 , detergent phase; Lane 2, aqueous phase;
Lane3 , pellet 1 (pellet obtained after inital homogenization of cells); Lane
, pellet 2 (pellet obtained after dialysis of detergent phase, prior to
eluted from the column.
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three days after infection of Sf9 cells but optimal expression of
farnesylated Ras occurs on the fourth day following infettion (Figure 17
panel A). Approximately 80% of the total Ras protein recovered from the
cell lysate is farnesylated. Ras proteins were purified by anion exchange
chromatography from Sf? lysates prepared in 1% Triton X- 114. The
Triton X- 114 phase partition method (194) was used to separate post-
translationally processed (farnesylated) Ras proteins from unprocessed Ras
proteins (Figure 17 , panel B). The faresylated Ras protein was parially
purified from the detergent-enriched phase and the unprocessed Ras was
parially purified from the aqueous phase. The detergent phase was applied
to an anion exchange column and eluted using a \linear N aCl gradient (0-
500 mM) in the presence of 0.5% DOC. The processed Ras began to elute
at 135 mM NaCl and was completely eluted at 310.5 mM NaCl (Figure
18, panels A and B). The anion exchange chromatography step failed to
significantly enhance the purity of the farnesylated Ras (Fig. 18, panel B
lane 1 and lanes 17-20). The partially purified faresylated Ras was
estimated to account for 0.7% of total Sf9 cell protein. The processed Ras
was able to bind eHJGDP efficiently, and the sensitivity of this assay could
be enhanced on the order of three-fold by immunoprecipitating the Ras
from the reaction instead of applying the typical method utilized in the high
literature which involves spotting the reaction on nitrocellulose (Figure 19
, .
panel A and panel B).
The parially purified Ras was used to determine if NCatHA and
NCatCHA could stimulate guanine nucleotide exchange in vitro. The assay
was initiated by aliquoting the equilibrated Ras into tubes containing
HJGTP and the NCatCHA or NCatHA (drained beads) which had been
immunoprecipitated from Sf9 cells. The final concentration of Ras in each
reaction was - 100 nM. The binding reactions were caried out for the
indicated times (10, 30, or 60 min) at 25 C. The NCatHA protein
stimulated the binding of (3HJGTP to the processed Ras with efficiency
comparable to that of full length dSOS, NCatCHA (Fig. 20 , panel A).
Relatively equal amounts of NCatHA and NCatCHA were
immunoprecipitated from Sf9 cells and used in the in vitro exchange assay
(Fig. 20, panel B) at the time points indicated in panel A. From this
western blot, it is impotant to point out that the amounts of both NCatHA
and NCatCHA seem to decrease as increasing time of incubation with Ras.
NCatHA and NCatCHA therefore seem to degrade to some extent with
increasing time at 25 C. Both NCatHA and NCatCHA enhanced the guanine
nucleotide exchange rate by approximately 5-fold when compared to the
spontaneous exchange reaction that occurs. Furthermore , NCatHA and
Figure 19. Binding of (3H)GDP to partially purified
farnesylated Ras. Ras (- .25 /-g) was incubated with 1.0 /-M (3HJGDP in
the presence of buffer for 30 min at 30 C. After the reaction was stopped
the amount of radioactivity associated with Ras was determned by the
following two methods. (A) Graphical representation of the amount of
HJGDP bound to Ras which was measured by the nitrocellulose filter
binding assay (176). Briefly, the reaction is spotted onto nitrocellulose
and the radioactivity associated with the nitrocellulose is determned using
a ~ counter. (B) Graphical representation of the amount of eHJGDP
bound to Ras which was determned by immunoprecipitating Ras from the
reaction. Briefly, Ras was immunoprecipitated using the anti-Ras antibody
(1742 cell supernatant) and goat-anti rat Sepharose. After incubation for 1
hour at 4 C, the beads were drained well and resuspended in 1.0 ml of opti-
fluor. The radioactivity associated with the beads was determined using a ~
counter.
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Figure 20. In Vitro stimulation of Ras activation by NCatHA
and NCatCHA. Baculovirus-infected Sf9 cells (NCatCHA and NCatHA)
were homogenized, and total protein was assayed using the Bradford
method. Lysates (- 5 mg) were incubated with anti-HA antibody and
Protein A-Sepharose overnight at 4 C. Immunoprecipitates were washed
and drained well. The exchange assay was initiated by adding equilibrated
Ras (100 nM) and 1.0 J.M (3H)GTP to the immunoprecipitated NCatCHA or
NCatHA. The binding reactions were carried out for the indicated times at
C. The Protein A-Sepharose was next pelleted, and the supernatant was
removed. The radioactivity bound to Ras was determned by
immunoprecipitating Ras from the supernatant (see Figure 19) and
counting the radioactivity associated with the beads using a ~ counter. (A)
Effects of immunoprecipitated NCatCHA and NCatHA on the kinetics of
GTP binding to Ras. Results are representive of at least two independent
experiments. (B) Anti-HA Western blot of the immunoprecipitated
NCatHA and NCatCHA. After the binding reaction was caried out for the
indicated times , the Protein A-Sepharose was pelleted and
immune complexes were analyzed. Immune complexes were separated by
SDS-P AGE and immunoblotted with the anti-HA antibody. Protein bands
were visualized by enhanced chemiluminescence (NEN).
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of eHJGTP to Ras after 30 min. NCatCHA and NCatHA were both able to
NCatCHA cause maximal binding catalyze the exchange of GDP for GTP
on processed Ras in vitro, confirming that they are active functional
proteins.
F. Expressed dSOS proteins were not found associated with endogenous
SOS in COS- 1 cells
Another trivial explanation to account for the data in Fig. 12 would
involve the ability of the endogenous SOS of COS- 1 / 293 cells to associate
with expressed NCatHA protein. As a result, GRB2 binding to the C-
terminus of the endogenous SOS of COS- 1 cells would result in the
recruitment of NCatHA to the plasma membrane where it can activate Ras.
In order to test this , COS- 1 cells were transiently transfected with NCatHA
and the HA-tagged protein was immunoprecipitated with the anti-
antibody (Fig. 21). Subsequent blotting of the anti-HA immunoprecipitate
with the anti-HA antibody revealed that the NCatHA protein is expressed
efficiently (Fig. 21, panel A). The endogenous SOS of COS- 1 cells is
detected in totallysates by immunoblotting with an anti-mSOS antibody and
the endogenous SOS migrates at the expected molecular weight of - 150
kDa (Fig. 21 , panel B). This anti-mSos antibody does seem to recognize a
Figure 21. Absence of detectable levels of dimers formed
between NCatHA and the endogenous mSOS of COS- . cells. (A)
Western blot of NCatHA from total lysate and anti-
(;'
immunoprecipitation. COS- 1 cells were transiently transfected with
NCatHA or vector alone. Forty eight hours after transfection cells were . :1
lysed in a 1 % TritonlO. 1 % Tween buffer. Total cell lysate (50 /-g) was
then separated by SDS-PAGE (6% acrylamide) and immunoblotted with
the anti-HA antibody. For the immunoprecipitation of NCatHA, cleared
lysate (1.0 mg protein) was incubated overnight with 30 /-1 of Protein-
:.":
Sepharose and 20 /-1 of anti-HA antibody. Immunoprecipitates were
washed and subsequently separated by SDS-PAGE (6% acrylamide) and
immunoblotted with the anti-HA antibody. Protein bands were visualized
by enhanced chemiluminescence. (B) Western blot of anti-
immunoprecipitates with the mSOS antibody (UBI). Total cell lysate (50
/-g) was also blotted with the anti-mSOS antibody in order to illustrate that
the mSOS antibody recognizes the endogenous SOS of COS- 1 cells.
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fair amount of nonspecific proteins indicating that the commercially
purchased antibody is not very specific. Immunoblotting of the
electrophoresed anti-HA immunoprecipitates with the anti-mSOS antibody
illustrated that there was no detectable dimerization occurring between
NCatHA and the endogenous SOS of COS- 1 cells. These results suggest
that dimerization of NCatHA protein with endogenous SOS of COS- 1 cells
cannot explain the ability of NCatHA to activate Ras in vivo.
G. Mapping of important functional domains in the amino terminus of
dSOS
Taken together, the results in the previous figures suggest that
structural elements within the NH terminal domain of dSOS are necessary
in order for the exchange activity of Cat to act on Ras in intact COS- 1 /
293 cells. Therefore , truncation and deletion mutants of the HA-tagged
NCat cDNA were engineered as represented schematically in Figure 22.
These dSOS constructs were designed such that two homology domains of
dSOS were focused on. One region in dSOS was previously identified to
contain sequence similarities to domains found in pleckstrin (158) which
represent amino acids 475-592 in dSOS. In addition, another region in
dSOS ( 250 amino acids) which is upstream and adjacent to the PH domain
Figure 22. Modulation of Ras GTP/GDP exchange in intact
cells by expression of truncation and deletion construCts of
NCatHA. (A) Schematic representation of the various dSOS constructs
which were tested for their ability to activate Ras in intact COS- 1 and 293
cells. (B) Autoradiogram (overexposed) of the TLC plate to visualize the
labeled guanine nucleotides which were bound to Ras. Human 293 cells
were transiently transfected via the CaPO 4- mediated method with Ras (2
Jlg) and the HA-tagged dSOS cDNAs shown (5 Jlg each). Cells were
labeled, and GDP and GTP associated with Ras was determned (see Figure
12). In each case , (n) represents the total number of experiments which
were performed utilizing the individual construct. For each construct the
PJGTP loading of Ras was calculated as the average percent GTP/GDP 
standard deviation. The basal level of Ras activation (1.21 0.44 (n=4)J
represents those cells which were transfected with Ras only (data not
shown). The value for the eZPJGTP/ezPJGDP ratio expressed as a percent
in cells cotransfected with NCatHA and Ras was 29. 9 (n=4), while
PH CatHA and NCat8PHHA were about 60% as effective.
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Figure 23. Sequence comparison of the PH domain of dSOS
with the PH domain of pleckstrin and the DBL domain . of dSOS
with DBL. (A) Alignment of the PH domain of dSOS with the PH
domain of pleckstrin. The shaded boxes show amino acids which are
identicaL Thee specific residues of the PH domain of pleckstrn have been
demonstrated to be important in binding PIP 2 in vitro and are labeled with
an asterik (*
). 
The only invariant amino acid among all PH domains is a
tryptophan (**). (B) Alignment of the third conserved region of the DBL
domain of dSOS with the same region within the DBL domain of DBL.
The shaded boxes show amino acids which are identicaL The region of
DBL that is most highly conserved among all members of the DBL family
is labeled with shaded circles above the residues.
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was identified to contain sequence similarties to a domain found in the
RHO guanine nucleotide exchange factor DBL (153, 154). In Figure 23,
the PH domain of pleckstrin was aligned with the PH domain of dSOS.
These two PH domains share 19% overall amino acid identity which is
represented by the shaded boxes. If conservative substitutions are counted
the PH domain of dSOS is 43% similar to that in pleckstrin. In addition, a
portion of the DBL domain of dSOS was aligned with a region of DBL
(Figure 23). The dots mark residues in DBL which have been shown by
mutation to be required for its transformng activity (157). This region
within the two DBL domains shares 18% overall amino acid identity which
is represented by the shaded boxes. If conservative substitutions are
counted, the entire DBL domain of dSOS (250 amino acids) is 30% similar
to that in DBL. The DBL domain consist of three conserved regions
referred to as I , II , and In which are separated by more variable
regions(153).
These dSOS cDNAs depicted in Figure 22 were cotransfected with
Ras cDNA into COS- 1 and 293 cells and cells were subsequently labeled
with eZPJorthophosphate as described previously. CatHA expression in 293
cells (Fig. 22, panel B , lane 7) failed to significantly enhance eZPJGTP
loading of Ras compared to transfection of Ras alone as was discovered
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previously in COS- 1 cells (Fig. 12). Remarkably, the PHCatHA construct
consisting of the pleckstrin homology (PH) domain amino-tenninal to the
Cat domain greatly stimulated ( p)GTP loading of Ras to levels
approaching those achieved with NCatHA (Fig. 22 compare lanes 2 and 4).
Immunofluorescence microscopy of the transfected 293 cells revealed that
all HA-tagged dSOS constructs depicted in Fig. 22 were expressed at
similar levels with the exception of NCatHA which was expressed at a
somewhat higher level. PHCatHA may therefore be as active as NCatHA in
this system when normalized for protein expression levels. These 
results
demonstrate for the first time a functional role for the PH domain of dSOS.
Interestingly, an NCatHA construct which has the p,H domain deleted was
also able to effectively stimulate eZp)GTP loading of Ras (Fig. 22
, panel B,
lane 3). However, basal levels of exchange activity were observed upon
deletion of the PH and DBL domains of NCatHA. Deletion of the PH
domain along with the DBL III region from NCatHA also resulted in basal
levels of exchange activity (Fig. 22, panel B, lanes 5 and 6).
Furthermore, addition of the region of the DBL domain (III) of dSOS
which correlates to the region in DBL that has been demonstrated to be
required for its transforming activity (154 157) failed to further enhance
the ability of the PHCatHA constrct to stimulate GTP loading of Ras (Fig.
Figure 24. Mutation of the invariant tryptophan in the PH
domain of dSOS had no effect on Ras activation in intact cells.
(A) 293 cells were transiently co-transfected with the Ras (2 Jlg) and the
HA-tagged dSOS cDNAs (5 Jlg each) shown. ( PJOrthophosphate-labeled
cells were then lysed, and the cleared lysate was immunoprecipitated with
anti-Ras antibody (1742 supernatant). The positions of the GTP and GDP
standards are indicated. Lane 1 represents cells that were transfected with
Ras only. (B) Graphic representation of Ras activation. The GTP and
GDP spots on the TLC plate were excised, and the amount of
p)orthophosphate incorporated was determned using a ~ counter. The
values shown represent the average of two individual experiments with
fJ-
1!:
ratio of GTP to GDP was calculated and expressed as a percentage , and the
vertical bars denoting standard errors. The leftmost bar on the graph
represents cells that were transfected with Ras only.
-=== :j,
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, lanes 3 and 8). Addition of this same region of the DBL domain (III)
of dSOS onto the catalytic domain of dSOS failed to cause Ras activation
when co-expressed with Ras in 293 cells (Fig. 24 , compare lanes 5 and 7).
As a control, the catalytic domain of dSoS was fused with a sequence
which specifies farnesylation and palmitoylation of Ras to its C-terminus in
order to target the catalytic domain of dSOS to the membrane. Somewhat
unexpectedly, this membrane targeted Cat construct (CatFAR) failed to
increase GTP-loading of Ras (Fig. 24, compare lanes 5 and 6) even though
CatFAR was processed and delivered to the membrane properly (see Fig.
28).
H. Mutation of the invarant tryptophan in the PH domain of dSOS
Based on the previous data, the PH homology domain of dSOS plays an
important role in activating Ras in intact cells. The degree of homology
shared among PH domains is actually fairly low. However, there is one
invariant tryptophan located near the C-termnus of all PH domains (Fig.
23). This tryptophan was mutated to a glycine in the PHCatHA constrct in
order to determine if mutation of this conserved amino acid would abolish
the ability of the PHCatHA to activate Ras in intact 293 cells. This mutant
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construct PHCatHA (w--::g) was transiently transfected into 293 cells along
with Ras. The cells were labeled in vivo with eZPJorthophosphate as
previously described and the amount of eZPJGTP loading on Ras was
measured. Figure 24 illustrates that the PHCatHA(w--
::g) 
mutant
stimulated eZPJGTP loading of Ras to relatively the same extent as
PHCatHA (Fig. 24 , compare lanes 3 and 4. Both PHCatHA and
PHCatHA(w--::g) were about 60% as effective as NCatHA in stimulating
GTP loading of Ras (Fig. 24, panel B).
I. Discussion
The data presented in this chapter suggest that the GRB2 binding
region of dSOS is not sufficient to allow the catalytic domain of dSOS to
function in COS- 1 or 293 cells. Therefore, the initial simple model
proposed in the literature which stresses that quantitative recruitment of
50S to the membrane via GRB2 binding is the main mechanism by which
SOS can activate Ras cannot be completely accurate. More specifically,
deletion of the C-terminus of dSOS resulted in a protein which could still
activate Ras in the intact cell (Figures 12 and 22) but was unable to bind
GRB2 (Figures 13, 14, and 16).
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Our data revealed an additional requirement for the NH terminal
domain of dSOS in Ras regulation. A simple hypothesis that explains this
data is that either the PH or DBL homology regions of dSOS are sufficient
to allow the catalytic domain of dSOS to interact with cellular Ras proteins.
Figure 22 illustrated that the absence of both of these regions in NCatHA
abolishes activity, while the presence of the PH domain positioned N-
terminal to the Cat domain confers high activity.
The data presented regarding the DBL domain of dSOS is not as
unequivocaL Comparison of two results in Fig. 22 suggest that the DBL
domain of dSOS contributes to the ability of the dSOS protein to activate
Ras in vivo. First, the deletion of the PH domain from NCatHA resulted in
a mutant dSOS protein which was still able to stimulate GTP-loading of
Ras. Second, the deletion of the PH and DBL domains of dSOS resulted in
a mutant dSOS protein which can no longer stimulate GTP loading of Ras.
Three additional dSOS deletion mutants were constructed to attempt to
address the relative contribution of the conserved regions which has not
been determined for any DBL domain-containing protein. The first
construct is referred to as DBL(III)CatHA consisting of a region of the
DBL homology domain NH terminal to the Cat domain (Fig. 24). The
second construct is referred to as DBL(III)PHCatHA consisting of both a
'11
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region of the DBL homology domain and the PH domain NHz termnal to
the Cat domain (Fig. 24). In the third construct the I and II conserved
regions of the DBL domain were deleted from NCatHA (Fig. 22). The
DBL(III)CatHA constrct failed to activate Ras in the intact cell and the
DBL(III)PHCatHA construct stimulated GTP-loading of Ras to the same
extent as PHCatHA. However, deletion of the entire DBL and PH domains
from NCatHA results in a dSOS mutant protein unable to activate Ras in
the intact cell. These results suggest that neither the DBL III region alone
or the DBL I and II regions in combination are sufficient to allow the Cat
domain of dSOS to activate Ras in the intact cell. Therefore, all three
regions of the DBL domain seem to be required for the ability of dSOS to
activate Ras in vivo. From the results presented here , it can be postulated
that the interaction of the PH and DBL homology regions of dSOS with
other elements in the cellular complexes that regulate Ras proteins are
necessar for the localization of the catalytic domain of dSOS and/or its
appropriate operation in intact cells.
The PH domain is an approximately 120 amino acid motif that was
first identified in pleckstrin, which is the major substrate for protein kinase
C (PKC) in platelets (195). This conserved motif is present in over 90
proteins, and several of these proteins playa role in signal transduction and
119
cytoskeletal functions (158,165). Ligands for PH domains have been
described, based on in vitro studies. These ligands include both proteins
such as the ~y subunit of heterotrimeric G proteins (171-174) and PKC
isoforms (196), and lipids , such as PIPz (166- 170) and PIP (170).
However, the importance of these interactions with PH domains in vivo
remains unclear.
Previous studies performed by Pitcher and co-workers illustrated
that a tryptophan which is invariant in all PH domain sequences is
important for the function of 
ARK (172). The PH domain of 
ARK is
able to interact with both G y and PIP at the carboxyl and amino termini
respectively (172). The interaction of these two lig'ands with ARK was
demonstrated to be required for both membrane association and activation
(172). A fusion protein consisting of the PH domain of ARK was able to
inhibit G !PIP t ~ARK activity in vitro (172). However, a
mutant fusion protein in which the invarant tryptophan was mutated to 
alanine failed to inhibit G !PIP dep ARK activity in vitro (172).
This experiment provided evidence that the tryptophan residue is important
for the function of ARK. Therefore, the tryptophan residue in the PH
domain of the dSOS PHCatHA construct was mutated to an glycine. Figure
24 shows that this mutant protein, PHCat(w-::g) is still able to activate Ras
I?(
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in the intact cell , suggesting that ligand binding to the the C-terminal
region of the PH domain of dSOS may not be essential for SOS function.
Several studies subsequent to ours also suggested that the PH domain
of SOS plays an important functional role. Injection of the PH domain of
hSOS 1 into Xenopus oocytes resulted in the induction of significant rates
of germinal vesicle breakdown and meiotic maturation (197). The
injection of the PH domains of IRS- ARK, and PLC8 failed to cause
germnal vesicle breakdown and meiotic maturation (197). Furthermore
the microinjected hSOS 1 PH domain cooperated with insulin or coinjected
normal Ras , but not progesterone, in the induction of Xenopus oocyte
maturation (197). These results suggested that the PH domain of hSOS 
plays a functional role.
Recently, evidence has been provided for the ability of the PH
domain of SOS to bind PIP and PIP . Kubiseski and co-workers
demonstrated that the PH domain of mSOS 1 binds liposomes containing PI-
in vitro with an apparent 
of 1.8 JlM (169). More specifically,
site-directed mutagenesis studies revealed that Arg
459
, a conserved basic
residue , plays an important role in the association with PIP (169).
Subsequently, Chen et al. showed that the PH domain derived from hSOS 
is able to bind with high affinity to PIP in vitro 5 JlM) and that
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when microinjected into COS cells or embryo fibroblasts , the hSOS 1 PH
domain seems to be enrched at the plasma membrane (198). Mutation of
the two residues previously shown to be critical for lipid binding (198),
Lys 456 and Arg 459, to glutamic acid residues resulted in a PH-SOS
protein unable to bind PIPz in vitro but still localized to the plasma
membrane after injection into COS cells (198). These experiments
published by Chen and co-workers suggested that PIP binding to the SOS
PH domain is not essential for its ability to associate with the plasma
membrane.
Recently, our lab in collaboration with Cantley s lab (Rameh et at.)
illustrated that the SOS PH domain binds to radioiabeled PI-3,4, with a
value that is submicromolar (170). These experiments also illustrated a
two-fold higher selectivity for binding to PI-3,4, over PI- (170).
Thus , the authors suggest that the conversion of PI- to PI-
PI 3- Kinase may contribute to the recruitment of SOS to the membrane
where PI 3- Kinase is activated. However, it is important to point out that
the PH domain of SOS only had a two-fold preference for PI-3,4, over
PI - 5- P z, suggesting that both of these lipids may playa role in
recruitment of SOS to the membrane where it can activate Ras.
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Chen et al. also provided evidence that the PH domain of SOS has a
dominant negative effect on serum-induced activation of the Ras signaling
pathway which was independent of PIP binding (198). More specifically,
COS cells were cotransfected with HA-tagged ERK2 and HA-tagged
deletion mutants of SOS (PH , PHKR-::EE' and 8CA T) and SOS associated
MAP kinase activity was measured 
in vitro. The three HA-tagged SOS
constructs inhibited MAP kinase activity by -75% (198). As a control Raf-
CAAX was expressed along with the PH domain. No inhibition was
observed in this case , suggesting that the dominant negative effect of the PH
domain of SOS is acting upstream of Ras. These experiments support the
idea that multiple domains of SOS are important for its ability to activate
Ras.
The data presented here also suggest that the COOH-terminal domain
of the dSOS protein may encode a negative regulatory domain. This is
supported by the observation that a construct consisting of the catalytic and
COOH-termnal domains of dSOS failed to activate Ras in intact cells (Fig.
12). Strong support of this hypothesis is provided by our collaborator
(Karlovich et al. experiments, in which genetic complementatio
was used
to show a dominant inhibitory function of CatC and physiological activity
of NCat in intact flies (Figs. 5 and 7). Aronheim 
et al. also demonstrated
1"1'
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that a faresylated full-length hSOS construct only partially complemented
CDC25 activity in a cdc25 temperature sensitive strain (185). However, a
farnesylated hSOS constrct which lacks the COOH-terminal domain was
able to completely complement CDC25 activity (185). Wang et al. have
also found enhanced transformng activity of a mutant mSOS protein which
lacks the COOH-terminal domain (199). From all of the above mentioned
results , GRB2 has been proposed to playa role in relieving an inhibitory
influence of the SOS COOH termnus.
The key resulted presented in this Chapter is that the GRB2 binding
region of dSOS is not necessary to allow the catalytic domain to function in
intact COS- 1 or 293 cells. Our data revealed an additional requirement for
the NH terminal domain of dSOS in Ras regulation. One possible model
that can be proposed is presented in Figure 25. This model postulates that
the function of the PH or DBL domains of dSOS may be to bind to
components that position dSOS to interact more favorably with membrane-
bound Ras , while GRB2 may playa role in relieving an inhibitory
influence of the SOS COOH terminus (Fig. 25). In addition to our data and
our collaborator s genetic experiments , Wang et ai. published results
which implied that the GRB2 binding domain of mSOS 1 is not required
124
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Figure 25. Model for the Role of NH2-terminal Domains
of dSOS in Faciltating GTP/GDP Exchange on Rasin Intact
Cells. Subsequent to the binding of GRB2-S0S\complexes
to tyrosine phosphate sites on receptor or receptor
substrate proteins (left), association of PH or DBL regions
in the SOS NH2-terminus to unknown components (?)
hypothetically position SOS to activate Ras. Alternatively,
SOS-GRB2 complexes may be anchored to the membrane
through binding of NH2-terminal sequences prior to
receptor activation and binding of GRB2 to tyrosine
phosphates (not shown).
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for downstream signal transduction (199). More specifically, they were
successful in isolating a dominantly transforming
mutant which was activated via deletion of the COOH-
terminus including
the GRB2 binding sites. Further analysis revealed that this mSOS 
1 mutant
protein was unable to associate with GRB2 
in vitro but, was still found
associated with the plasma membrane in the Rat1 transformed cells (199).
These experiments also argue that SOS proteins do not require GRB2
binding in order to interact with the plasma 
membrane.
More recently, Byrne 
et al. investigated both the requirement for
the GRB2/S0S association and the functional role of varous domains of
SOS using Ras-dependent signaling pathways (200). In their system, the
hSOS C-terminal domain was able to inhibit PC12 cell differentiation,
NIH3T3 cell proliferation, and ERK2 activation (200) by sequestering the
endogenous GRB2, which suggested that the GRB2/S0S interaction was
required for Ras activation. This inhibitory 
effect was rescued by
expression of a full-length hSOS construct or GRB2 (200).
Furthermore, Byrne 
et al. examined how various SOS constructs
effected NIH3T3 cell proliferation and ERK2 activation (200). Their
studies provided evidence confirmng our initial 
finding that the amino-
termnal domain of SOS is important for its function and that the C-
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terminal domain of SOS plays an inhibitory role. They demonstrated that a
construct consisting of the exchange factor domain (EFD) of SOS, which is
equivalent to our CatHA construct, failed to replenish ligand-stimulated
ERK2 activation in NIH3T3 cells expressing the C-terminal domain of
SOS. However, a construct comprising both the SOS N-termnal and
catalytic domains (NterEFD) was able to rescue the inhibitory effects that
the SOS C-terminal domain had on NIH3T3 cell proliferatio and ERK2
activation (200). A construct containing the catalytic and C-terminal
domains (EFDCter) was able to parially suppress the inhibitory effect of
the SOS C-termnal domain on ERK2 activation but failed to restore DNA
synthesis in NIH3T3 cells expressing the C-terminal domain of SOS (200).
These findings suggest that the C-termnal region of SOS does contribute to
the activation of Ras via growth factors , but the major signal seems to be
relayed through the NHz termnal domain of SOS. Based on their
findings , the authors proposed a model similar to ours (Fig. 25) which
postulates that SOS is activated as the result of two ligand-dependent steps:
1.) the association of SOS/GRB2 complexes with RTK' s or phosphotyrosi
signaling proteins , such as SHC, which may lead to the initial recruitment
of SOS to the membrane and 2.) a second event involving the SOS N-
termnal domain that is required for SOS to activate Ras.
. .,. . ".'
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Strong support of our data and the conclusions drawn is provided by
genetic experiments from our collaborators (188) , a combination of
genetic and biochemical experiments performed by Wang and co-workers
(199), and the more recent data of Byrne and co-workers (200).
Therefore, the striing similarity of results obtained by these independent
methodologies suggest that regions within the NHz termnal region of the
SOS protein are necessary for their physiological function. The simple
recruitment model which proposes that SOS is activated as a result of its
recruitment to the membrane via GRB2 binding seems to be incorrect
based on our findings and several other groups. The data suggest that a
second unclear event must occur involving the SOS N-termnal domain in
order for SOS to catalyze guanine nucleotide exchange on Ras. 
Strong
evidence is also provided for the C-terminal domain of SOS playing an
important role in the down-regulation of the Ras signaling pathway.
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CHAPTER V
LOCALIZATION OF DSOS MUTANT PROTEINS IN CELLS
A. Specific Aims and Rationale
The specific aim of this Chapter is to test the hypothesis that the
amino-termnal domain of dSOS , specifically the PH and DBL regions , is
important for its membrane association. Several proteins containing PH
domains have been demonstrated to require membrane association for their
function. Evidence has also been provided which illustrates that several PH
domains can bind to lipid molecules such as PIP in vitro. Therefore , it has
been proposed that the interaction of PH domains ard phospholipids may be
one possible mechanism by which PH-domain containing proteins are
anchored to the membrane (Figure 26). The rationale to test this proposed
model is based on our previous observation that either the PH or DBL
homology regions of dSOS were sufficient to allow the catalytic domain of
dSOS to interact with cellular RAS proteins. This will help to determne if
simple recruitment of dSOS to the plasma membrane is the mechanism by
which dSOS is activated. Another alternative would be that once dSOS is
recruited to the plasma membrane binding of a yet unidentified component
to the PHlBL region is necessary for the ability of SOS to activate RAS in
129
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Figure 26. Model for the role of the PHlBL domais of dSOS
in localizing dSOS to plasma membrane. The binding of lipid
molecules to the amino-termnal domain of dSOS (PH and DBL
regions) may be important for the association of dSOS with
the plasma membrane where it can activate Ras.
'\ '
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the intact cell. In order to test the proposed hypothesis two specific
questions were addressed: 1.) What is the distribution of various dSOS
mutant proteins in 293 cells? and 2.) Can neomycin inhibit the ability of
various dSOS mutant proteins to associate with total membranes in 293
cells?
B. Distribution of dSOS mutant proteins in 293 cells
293 cells were transfected with the varous HA-tagged dSOS mutant
proteins and cytosolic and total membrane fractions were prepared in
order to determine if membrane association of a specific construct is
sufficient for its ability to activate RAS. 293 cells were transiently
transfected with the following HA-tagged dSOS mutant cDNA constructS:
NCat, NCat(8PH), NCat(8200), NCatC, CatC , C, Cat, and Cat-tagged with
the RAS farnesylation sequence (refer to Figs. 9 and 22). Cells were
homogenized and initially centrifuged at a low speed in order to remove
nuclei and unbroken cells. Next, the homogenate was centrifuged and
separated into cytosolic and total membrane fractions. Protein in the
cytosol and membrane fractions was quantitated and equal amounts of HA-
tagged dSOS proteins were immunoprecipitated using a polyclonal anti-
antibody. Immunoprecipitates were separated by SDS-PAGE and
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subsequently immunoblotted using a monoclonal anti-HA antibody (Fig.
27).
The data from these fractionation experiments suggest that the
amino-terminal domain of dSOS is important for the ability of dSOS to
associate with cell membranes. This is supported by the finding that
constructs that lack the amino termnus , CatC and C, are predominantly
cytosolic (Figure 27). More specifically, 90% of the expressed CatC is
found in the cytosol and 85% of the expressed C is found in the cytosol
(Figure 28). Three of the constructs, NCatHA, NCat8PHHA, and
NCat8200HA were relatively equally distributed among the cytosolic and
total membrane fractions (Figs. 27 and 28). In add tion, the Cat domain
alone was expressed and found predominantly associated with the cytosolic
fraction (Fig. 27). These observations suggest that the amino-termnal
domain of the dSOS protein plays a role in its association with the total
membrane fraction in transiently transfected 293 cells.
These fractionation experiments also provide evidence to support the
hypothesis that the C-terminal domain of SOS plays an inhibitory role.
The data suggest that the CoOH-terminus may inhibit membrane
association since NCatC, CatC and C seem to be predominantly cytosolic
whereas removal of the COOH-terminus (NCat) results in a 5-
:r:
Figure 27. Distribution of dSOS mutant proteins in 293 cells.
(A) Anti-HA western blot of NCatHA, NCatCHA, NCatDPHHA
NCat8200HA, CatCHA, and CHA immunoprecipitates from cytosol (S) and
total membrane fractions (P). (B) Anti-HA western blot of CatHA and
CatFARHA immunoprecipitates from cytosol (S) and total membrane
fractions (P). 293 cells were transiently transfected with the indicated HA-
tagged dSOS constructs and cytosol and total membrane fractions were
prepared (see Fig. 14). Total protein in the cytosol and membrane fraction
was determned and HA-tagged dSOS proteins were immunoprecipitated
from both fractions. Immunoprecipitates were separated by SDS- PAGE
and blotted using a 1/1000 dilution of the monoclonal anti HA antibody.
Protein bands were visualized by enhanced chemilumiescence.
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fold increase in the amount associated with the total membrane fraction
(Figs. 28). Therefore, it can be postulated that GRB2 may be regulating
the localization of dSOS as previously discussed in Chapter IV , but through
an indirect mechanism involving relief of repression of the COoH-terminal
inhibitory effects on the amino-terminus.
The data from these fractionation studies in conjunction with the data
from the in vivo RAS activation experiments together suggest that
localization of dSOS to the membrane is not sufficient for its ability to
activate RAS. The construct lacking half of the DBL domain and the entire
PH domain (Ncat8200) was found associated with total membranes (Figs.
27 and 28) but failed to activate RAS in the intact 293 cells (Fig. 22). 
addition, tagging of the Cat domain with the RAS faresylation sequence
resulted in a significant increase in the amount of Cat associated with total
membranes (-90%). However, this construct also failed to activate RAS in
the intact cell (Figs. 27 and 28). The presence of an intact DBL or PH
domain therefore seems to be required for the ability of dSOS to activate
RAS, but is not necessary for dSOS to be associated with the total
membranes.
Figure 28. Graphical representation of the amount of dSOS
mutant proteins present in the soluble and particulate fractions
of transfected 293 cells. The data shown in Figure 27 , along with data
from repeated experiments , were quantitated using a scanning
densitometer. The data is expressed as a ratio of the numerical value
obtained from densitometric scanning of the expressed protein bands in the
soluble or pariculate fractions to the sum of the total expressed protein in
both fractions. The ratio obtained represents the percentage of the
indicated protein in either the soluble or pariculate fraction. The total
number of experiments (n) which were performed utilizing the individual
constructs are listed as follows: NCatHA, n=13; NCatCHA, n=4;
NCat8PHHA, n=14; NCato200HA, n=4; CatCHA, n=5; CHA, n=3; and
CatF ARHA, n=5.
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C. Release of dSOS mutant proteins from total membranes upon treatment
with neomycin
293 cells were transiently transfected with either NCatHA or
NCat8PHHA cDNA constructs and total membranes were prepared as
described in the previous section. Total membranes were next resuspended
in the presence or absence of neomycin (15 or 40 J.M) and incubated at 4
for 10 min on an end-over-end rotating mixer. Total membranes were
again pelleted, and the supernatants were saved to determine the quantity of
the dSOS proteins released from the membranes. Thb HA-tagged dSOS
proteins were immunoprecipitated from the cytosol, total membrane, and
the supernatant after neomycin treatment (released fraction) using a
polyclonal anti-HA antibody. Immunoprecipitates were separated by SDS-
PAGE and subsequently immunoblotted using a monoclonal anti-
antibody (Fig. 29).
The data presented in Figures 29 and 30 suggest that lipid binding to
the dSOS amino-terminus may playa role in the association of NCatHA and
NCat8PHHA with total membranes in transfected 293 cells. Treatment of
prepared total membranes (particulate fraction) with 15 J.M neomycin
Figure 29. Release of NCatHA and NCat8PHHA from total
membranes upon treatment with neomycin. Cells were fractionated
as previously described in Fig. 27. Total membranes were resuspended
and incubated for 10 min at 4 C in the presence or absence of neomycin
(40 f.M). Total membranes were again pelleted and the resulting
supernatant (Releas. ) , along with the cytosol (S) and total membrane pellet
(P), was analyzed for indicated HA-tagged dSos constructs as described
previously in Fig. 27. Anti-HA immunoprecipitates were separated by
SDS-PAGE and blotted using the monoclonal anti-HA antibody. Protein
bands were visualized by enhanced chemiluminescence.
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Figure 30. Graphical representation of the amount of NCatHA
and NCat8PHHA released from total membranes upon neomycin
treatment. The data shown in Figure 26 , along with data from a
repeated experiment, were quantitated using a scanning densitometer. The
data is expressed as a ratio of the numerical value obtained from
densitometric scanning of the expressed protein bands in the soluble
particulate , or released (after neomycin treatment) fractions to the sum of
the total expressed protein in all fractions. The ratio obtained represents
the percentage of the indicated protein in either the soluble , particulate, or
released fraction. Standard errors are denoted by vertical bars. The
absence of error bars indicates that the experiment was only performed
once.
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resulted in only a small percentage of the NCatHA being released (10%)
and no release of the NCat8PHHA (Fig. 30). However, treatment of
prepared total membranes with 40 J.M neomycin resulted in a significant
percentage of the NCatHA and NCat8PHHA being released
, -
44% and 38%
respectively (Fig. 30). Neomycin therefore seems to release both NCatHA
and NCatbPHHA from total membranes presumably via binding the PIP
lipid molecules. Published in vitro studies suggest that PIP z is able to bind
to the SOS PH domain (169, 170). Our neomycin experiments suggest that
PIP z may be interacting with regions in the amino-termnus of dSOS other
than the PH domai.
D. Discussion
The data presented in this Chapter suggest that the amino-terminus of
dSOS is important for its ability to associate with total membranes in
transfected cells. Deletion of the PH domain from NCatHA resulted in a
dSOS mutant protein which is still able to associate with the pariculate
fraction suggesting that additional regions in the NH terminus may
contribute to the association of dSOS with total membranes (Figs. 27 and
143
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28). In addition , deletion of the PH domain and half of the DBL domain
resulted in a dSOS mutant protein which was still capable of associating
with the particulate fraction in transfected 293 cells (Figs. 27 and 28). The
CatHA construct in which the entire NH terminus is deleted failed to
associate with the particulate fraction significantly (Fig. 27). Tagging of
the CatHA construct with the RAS farnesylation sequence resulted in a
significant increase in association of the CatHA dSOS mutant protein with
the particulate fraction. Taken together, these results suggest that regions
upstream of the Cat domain of dSOS contribute to the ability of dSOS to
associate with the particulate fraction in intact cells.
The fractionation experiments and the in vivo 
\RAS activation
experiments together illustrate that the amino-terminal domain of dSOS
plays an important role in its function. The amino-termnus is necessary
for membrane association and RAS activation in intact cells. The
amino glycoside antibiotic neomycin was used to determine if PIP z is
contributing to the association of the dSOS constructs NCatHA and
NCat8PHHA with the membranes prepared from 293 cells. Neomycin is
an antibiotic that exhibits a specific affinity for PI- P and PI-
(214 215). This is believed to result from a strong ionic interaction
between the cluster of six primary amino groups on the neomycin and the
1 " !!!f
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several negatively charged phosphate groups on the lipid molecules. 
vitro studies utilizing bilayer vesicles consisting of PI- revealed that
10 M neomycin binds greater than 50% of the PIPz in the bilayer (215).
The NCatHA construct was released from total membranes upon
treatment with neomycin (Figs. 30 and 31). Therefore , one possible
explanation for this result is that neomycin may be binding the cellular
PIP z, and therefore prevents the PIP z from associating with the PH domain
of NCatHA. The ability of neomycin to release NCat8PHHA from the total
membranes was also tested. Surprisingly, NCat8PHHA was also released
from the total membranes upon neomycin treatment, suggesting that
multiple regions in the amino-terminus of dSOS may be capable of binding
PIPz. Upon careful examination of the entire DBL domain, regions were
found that contained charged basic residues. Therefore, one possibility is
that PIP or some another negatively charged molecule may be able to
associate with the DBL domain of dSOS and anchor it to the membrane
where it can activate RAS. These neomycin experiments and the published
in vitro studies demonstrating PIP z binding to the SOS PH domain suggest
that lipid association with the SOS amino-termnus may be one mechanism
by which SOS is associated with the membrane.
145
"'fi
In a similar manner Wang et al. used Rat1 cells
(Rat1pMFGmSos1.2A) which were infected with the retioviral vector
carying the msos 1 gene to determne the localization of the SOS proteins
(199). This cell line expressed both a transformation-associated protein
referred to as p1358msosl , which lacks the COOH-terminus , and endogenous
SOS1 proteins (196). Fractionation of these cells revealed that the
endogenous and transforming SOS 1 proteins (COOH-terminal truncation)
were found relatively to the same extent in the soluble and particulate
fractions. In this system, it is important to point out that expression levels
achieved are relatively high. In our system which utilized transiently
transfected 293 cells , the NCatHA construct was also found relatively
equally distributed among the soluble and particulate fractions at high and
low expression levels. However, NCatCHA in the transfected 293 cells was
found predominantly in the soluble fraction but, as increasing amounts of
NCatCHA are expressed, more seems to become associated with the
pariculate fraction (data not shown). Therefore, our data seems to be in
agreement with the data presented by Wang and co-workers.
While our studies suggest that the amino-terminus of dSOS is
important for membrane association and RAS activation in intact cells,
individual studies by Aronheim et al. 
(185) and Quilliam et at. (201)
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provide evidence that the targeting of hSOS to the membrane is the
primary mechanism leading to activation of the RAS sigrialing pathway.
Aronheim and co-workers generated modified hSOS constructs: the full
length SOS containing either the v-SRC myristoylation signal or the Ha-
RAS famesylation and palmitoylation signal and a C-terminally truncated
SOS containing the same membrane targeting sequences. These modified
and unmodified SOS constructs were transfected into He La cells and
fractionation studies along with immunofluorescence studies confirmed that
only the modified constructs were targeted to the membrane (185). These
results are inconsistent with results from our experiments Wang et at.
experiments , and Karlovich et at. experiments which \ clearly show that both
full-length and C-terminally truncated mSOS and dSOS constructs are
found associated with the total membrane fraction without being arificially
targeted (188, 199). Furthermore, these constructs were transiently
transfected into NIH3T3 cells and tested for their ability to stimulate the
RAS signaling pathway. Only the modified constructs were able to activate
AP- 1 and ERK1 (185). Analysis of NIH3T3 cells stably transfected with
the modified and unmodified constructs revealed that only the modified
contructs resulted in neoplastic transformation. Interestingly, the modified
SOS construct lacking the C-terminus was much more efficient in
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transformation then the modified full-length SOS construct, supporting the
previously mentioned hypothesis that the C-terminal domain of SOS may
play an inhibitory role (185). The modified SOS constructs were also
capable of suppressing the cdc25 temperature-sensitive phenotype , whereas
the unmodified constructs failed to suppress the 
cdc25 phenotype (185).
These results are inconsistent with genetic studies performed by Karlovich
et at. which demonstrated that the wild-type dSOS and a dSOS construct
lacking the COOH-terminus were both able to suppress the temperature-
sensitive cdc25 phenotype (188). These artificial membrane localization
studies suggest that targeting of SOS to the plasma membrane appears to be
the primar mechanism leading to activation of the RAS signaling pathway,
suggesting that the accessibility of SOS to RAS is the rate limiting step in
signal transduction. The authors therefore proposed a model suggesting
that upon activation of growth factor receptors , SOS is targeted to the
membrane via GRB2 which results in RAS activation.
In summary, the model in which the main mechanism for
recruitment of SOS is through GRB2 cannot completely explain how SOS
activates RAS in the intact cell. Our results show that a construct lacking
the GRB2 binding domain is found associates to a significant extent with
the particulate fraction and also can activate RAS. Furthermore, 
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construct that lacks the GRB2 binding domain , PH domain, and half of the
DBL domain also associates with the pariculate fraction although this
construct fails to activate RAS in the intact cell. In a similar manner, when
the Cat domain is modified with a membrane targeting sequence , it is
targeted to the membrane but unable to activate RAS. All of these results
suggest that regions upstream of the Cat domain are important for the
ability of SOS to activate RAS in the intact cell. Karlovich and co-workers
also showed using genetic experiments that a dSOS construct lacking the
GRB2 binding domain was fully active whereas , a construct lacking the
termnus had a dominant negative effect (188). In addition , Wang 
at. illustrated that a MSOS construct lacking the G:R2 binding domain
was capable of transforming Rat1 cells and also could associate with the
particulate fraction in these cells (199). However, genetic studies in both
worms and flies provide evidence that GRB2 proteins function as rate
limiting positive elements in the RAS signaling pathway. However, the
mechanism by which GRB2 operates is unclear. Thus , the proper
, presentation of SOS to RAS seems to involve multiple intermolecular
interactions in which both the NHz and COoH-terminal domains of SOS
participate.
'''!
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CHAPTER VI
CONCLUSIONS AND FUTURE WORK
A. Possible Mechanisms for SOS Activation
Ras proteins are critical downstream components of receptor protein
tyrosine kinases. The mechanism by which SOS activates Ras remains
unclear. Three possible models have been proposed for the mechanism by
which SOS activates Ras. The first model postulates that allosteric
activation of SOS may occur upon association with the complex of activated
receptor and GRB2. However in vitro studies have shown that when the
GRB2 SH2 domain is bound to a phosphotyrosine peptide derived from the
EGFR , there is no change in the affinity of the SH3 domain of GRB2 for
proline-rich SOS derived peptides (217). These data suggest that allosteric
activation of SOS via GRB2 is not the main mechanism by which SOS can
activate Ras.
The second model proposes that phosphorylation of SOS via protein
tyrosine kinases may activate its exchange activity. SOS has multiple
phosphorylation sites , but there are no detectable phosphotyrosines. Upon
simulation with growth factors , SOS becomes phosphorylated on serine and
threonine residues an event that can be detected by its decreased mobility
'''''!
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on SDS polyacrylamide gels (52,177 218,219). Several groups have
confirmed that SOS is phosphorylated in vitro and in vivo by MAP kinase
(220-222). Very recently, p90 RSK-2 kinase has been shown to
phosphorylate SOS in vitro and in vivo after treatment of PC12 cells with
EGF (223). In both cases, no change in SOS exchange activity has yet been
demonstrated upon its phosphorylation. Phosphorylation of SOS seems to
occur with a time course which lags behind Ras activation and MAP kinase
activation (219,224). The published data suggest that phosphorylation of
SOS does not seem to activate Ras but, instead, may inhibit Ras as a result
of the dissociation of SOS from GRB2 or the dissociation of the SOS-GRB2
complex from the receptor (225-227).
Two findings have led to the development of the last model: 1.) the
failure of growth factors to induce changes in SOS activity (176) and 2.
the detection of complexes consisting of either receptor/GRB2/S0S or
SHC/GRB2/S0S (176). The last model proposes that the translocation of
SOS to the membrane via GRB2 results in its ability to activate Ras simply
through a proximity effect. Limited evidence for this model is provided
by two related studies (see Chapter V Discussion) in which the GNEF'
SOS and CDC25 were targeted to the plasma membrane via an arificial
ii;,
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localization signal (185,201). As a result, SOS/CDC25 were targeted to the
plasma membrane and were able to activate the Ras signaling pathway.
B. Summary of Findings
Our experimental observations along with those of others in the field
argue that the simple recruitment model proposed to explain SOS activation
is not completely accurate. Our data clearly show that the amino-terminal
domain of SOS plays an important role in its ability to activate Ras based
on the findings that a construct lacking the NH terminus , CatCHA, was
unable to activate Ras in intact cells whereas, a construct lacking the C-
termnal GRB2 binding domain was fully capable of activating Ras in the
intact cell. Furthermore, analysis of the NH terminal domain revealed
that either the PH and/or DBL domains of dSOS are required for GTP
loading of Ras. Our data illustrate that proper localization of the catalytic
domain of SOS to the membrane is insufficient to cause activation of Ras.
More specifically, deletion of both the PH and DBL (III) regions from
NCatHA results in a construct that is targeted to the membrane but is
unable to cause GTP loading of Ras. In the same manner, the CatFAR
construct which consists of the catalytic domain fused to the Ras membrane
targeting sequence failed to activate Ras but was found associated with the
'-"
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pariculate fraction. Our findings suggest that in addition to the interaction
of SOS with GRB2 , there is an unkown interaction involving the NH
terminus of SOS which is important for its function. Therefore, the proper
presentation of SOS to Ras seems to be achieved through multiple
intermolecular interactions involving both the amino and carboxy-termnal
domains of the protein.
C. Future Directions
1. Is there a specific ligand for the PH and or DBL domain of SOS?
Our data demonstrates a functional role for the PH and DBL domains
within the dSOS protein. It can be postulated that the function of the PH or
DBL regions of dSOS is to bind membrane components that position dSOS
to better interact with membrane-bound Ras. In vitro data show that both
PIP and PIP can bind to the PH domain of SOS, suggesting that lipid may
be the unidentified membrane component that positions dSoS to interact
with cellular Ras (169 170). However, recent data published by Chen et al.
illustrate that mutations in the PH domain of SOS that abolish lipid binding
do not effect the ability of the PH domain to associate with the plasma
membrane (198). Thus , identification of potentialligands for the PH
Ie,
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domain of SOS will help to shed light on the mechanism by which SOS
activates Ras.
Several experiments can be proposed to determne if there is an
important physiological ligand for the PH domain of SOS. One possibility
would be to screen an expression library using radiolabeled SOS PH
domain as a probe. In addition, total membranes could be prepared from
radiolabeled cells, and incubated with the fusion proteins GST-NCat and
GST - NCat3PH. This experiment may reveal if any radiolabe1ed membrane
proteins are associating with SOS via its PH domain. More specificaly,
293 or COS- 1 cells would be radiolabeled, stimulated with EGF, and
subsequently fractionated into cytosol and total membranes. The prepared
total membranes would next be incubated with NCat and NCat3PH
recombinant proteins in order to determne if any membrane proteins are
found preferentially associated with recombinant NCat protein versus
NCat8PH. In the same type of experiment, prepared total membranes from
radiolabeled cells could be incubated with a fusion protein consisting of
only the SOS PH domain, GST-PH. These above experiments may help to
reveal if there is a protein ligand for the PH domain of SOS that is
important for the ability of SOS to activate Ras.
; 0
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2. Coordinated regulation of Rho/Rac and Ras activities
..,
Members of the Rho family of small GTP-binding proteins include
Cdc42 , Rae , and Rho (8). Each of these Rho-family members induces
unique morphological changes , that involve rearrangement of the F-actin
when microinjected into Swiss 3T3 fibroblasts (228). More specifically,
I .
microinjection of a constitutively active Cdc42 induces filopodia, Rae
induces membrane ruffles , and Rho induces stress fibers (228). Studies
have illustrated that Rho, Rac, and Cdc42 regulate a signal transduction
pathway in Swiss 3T3 cells linkng extracellular signals to the organization
of the actin cytoskeleton (229-231). In addition, one member of the family
can activate another: Cdc42 can activate Rae which oan then activate Rho
(228).
The presence of two catalytic domains in DBL family members
suggests that they may act as multifunctional proteins linking signaling
pathways. SOS has both a CDC25 homology domain that encodes the Ras
GEF activity and the DBL homology domain that potentially encodes Rho
GEF activity. Bar- Sagi et at. through both microinjection of recombinant
proteins and by analysis of cell lines transformed by Ras demonstrated that
activatedRas proteins are capable of inducing membrane ruffling (232).
Subsequently, Ridley et at. illustrated that both Rac and Rho proteins are
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required in order for Ras to stimulate reorganization of the actin
cytoskeleton suggesting that Ras is acting upstream of Rae and Rho (230).
Expression of activated Rac along with RAFCAAX in NIH3T3 cells results
in an increase in transforming activity compared to each transfected
individually (233). This indicated that Rae and MAPK pathways cooperate
to cause cellular transformation. Through the use of Ras mutant proteins
oneson et at. recently provided evidence that Ras controls both membrane
ruffling and MAPK activation by distinct effector systems (234). Data
therefore has been emerging supporting the idea that the Ras and Rho/Rac
signaling pathways are linked.
Several experiments can be proposed to test if SOS plays a role in
linkng the Ras/Ro signaling pathways. One intriguing question is
whether SOS can exhibit exchange activity towards Rho family proteins.
This can be easily tested by looking at the ability of the DBL domain of
SOS to catalyze exchange on GST-Rho , GST-Rac , and GST-Cdc42 in vitro.
Another possibility is that SOS may serve to regulate Rho family members
and not actually catalyze exchange. Recently, a Cdc42/Rac interactive
binding (CRIB) motif has been identified which consists of approximately
16 amino acids (236). Upon examination of the dSOS sequence, there is a
potential CRIB motif which is located within the DBL homology domain.
.. 
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Therefore , it would be feasible to determne if SOS is able to associate with
Rac , Rho, or Cdc42 and determine if this association is nucleotide
dependent. I have recently constructed a SOS GST DBL fusion protein.
Preliminary results from experiments performed by Dr. Andrew
Chemiack in this laboratory suggest that the DBL domain of SOS is able to
associate with Rae in vitro. More specifically, the SOS GST-DBL protein
was incubated with lysates prepared from COS- 1 cells overexpressing myc-
Rae , i.e. , Rae with a myc epitope at the NHz termnus. In addition , 3T3L1
adipocytes could be used as a model system to determne if insulin triggers
the association of SOS with Rae in vivo. If a complex of SOS and Rae is
observed, one question that should be addressed is what is the
phosphorylation state of SOS. The presence of multiple domains (DBL and
PH domains) in several DBL-like GNEFs suggest a possibility for merging
of signaling pathways and/or an additional level of regulation for
individual GNEF activities.
In order to begin to delineate a role for the DBL domain of SOS, 
have recently tested whether expression of NCatHA and NCat8PHHA have
an effect on actin organization. As illustrated in Figures 31 and 32
preliminary results suggest that both of these dSOS constructs cause
reorganization of the actin cytoskeleton when overexpressed in COS-
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cells, as compared to cells that were mock transfected with pCMV5. 
Figure 31 (panels A-D) COS- 1 cells were mock transfected with the
pCMV5 vector, and the presence of long stress fibers was detected by actin
staining using rhodamine-labelled phalloidin. Both NCatHA (panels E and
G) and NCat8PHHA (panels I and K) were successfully expressed in COS-
1 cells as detected by incubation with the polyc1onal anti-HA antibody
followed by staining with FITC-conjugated goat anti-rabbit IgG. Staining
of the cells expressing NCatHA and NCat8PHHA with rhodamine-labelled
phalloidin revealed that both of these SOS constructs seem to affect the
actin cytoskeleton (Figure 31, panels J, and L). More specifically,
expression of NCatHA and NCat8PHHA seems to result in both a decrease
in the number of long stress fibers in the cell and the formation of actin
foci in the cytoplasm. Both of these events suggest that expression of
NCatHA or NCat8PHHA in COS- 1 cells causes a reorganization of the actin
cytoskeleton, most likely via an event involving the DBL domain of SOS.
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Figure 31. Reorganization of the Actin Cytoskeleton by
NCatHA and NCatbPHHA. COS- 1 cells were plated on coverslips and
transiently transfected with either vector alone (pCMV5), NCatHA, or
NCatbPHHA. Approximately 48 hours after transfection cells were fixed
and permeablilized as described in the Methods chapter. Cells were
subsequently incubated for two hours with the-anti-HA antibody. The cells
were next washed and incubated with FITC-conjugated goat anti-rabbit IgG
and rhodamne labelled phalloidin. Cells were mounted and
immunofluorescence was visualized by digital imaging microscopy. Panels
COS- 1 cells were mock transfected with pCMV5 and stained with
rhodamine labeled phalloidin. Panels COS- 1 cells were transfected
with NCatHA and expression was detected-by anti-HA; FITC-conjugated
goat anti-rabbit IgG staining (panels E and G). The same cells shown in
panels E and G were also examined for actin filaments using rhodamine-
and - 150 cells were scored for each condition.
labelled phalloidin (panels F and H respectively). Panels COS- 1 cells
were transfected with NCatbPHHA (panels I and K) and expression was
detected as described above for NCatHA. The same cells shown in panels J
and L were also examined for actin filaments using rhodamine-labelled
phalloidin. The results are representative for two independent experiments
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Figure 32. Graphical Representation of the Percent of COS-
cells Expressing NCatHA and NCat8PHHA which Exhibit
Reorganization of the Actin Cytoskeleton. Quantitation of the data
presented in Figure 31. More specifically, for each transfection condition
150 cells were scored for two phenotypes: 1.) the presence of long stress
fibers and 2.) disappearance of long stress fibers and the formation of foci
of actin near the periphery of the cell. The results are a summary of two
independent experiments.
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Presently, I am testing if any of the following dSOS constructs have an
effect on the actin cytoskeleton: NHA, CatCHA, NCat8200HA, and
NCatCHA. Preliminar results suggest that the NH terminal domain alone
of dSOS exhibits the phenotype described for both NCatHA and
NCatoPHHA, whereas expression of the dSOS construct which deletes the
termnal domain does not seem to display this phenotype. However
the experiment with the NHA and CatCHA constructs has only been
performed once. Initial results suggest that SOS may playa role in
reorganization of the actin cytoskeleton presumably via the DBL domain.
Therefore, it would be interesting to determne if this is occurring in a
Ras-independent or Ras-dependent manner.
3. Determnation of the three-dimensional structure of domains of SOS
Ultimately, in order to understand the specific mechanism by which
GNEF' s promote nucleotide exchange on Ras , detailed structural studies
need to be performed. Several labs have demonstrated that GNEFs
catalyze nucleotide exchange by stabilizing the apoRas intermediate (235).
Using Ras mutants , residues critical for interaction with GNEF's have been
identified. More specifically, NMR analysis of the Ras mutant protein
Ras(E69N), a mutant that is unable to associate with CDC25, indicated that
-.-. " - .,-- . - -  -
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no structural changes were occurrng outside the switch 2 region which
suggest that GNEFs interact with the switch 2 region of Ras (236 237). In
addition to understanding the residues in Ras involved, it is important to
understand how the domains in SOS contribute to the activation of Ras.
Detailed structural studies of the DBL, PH, and CDC25 homology domains
of SOS independently and in combination may aid in understanding the
mechanism by which SOS activates Ras , and potentially, Rho family
members.
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